SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2024

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from               to               

 

Commission file number 001-40747

 

 

authID Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   46-2069547

(State or other jurisdiction of

incorporation or organization)

  (I.R.S. Employer
Identification No.)

 

1580 North Logan Street, Suite 660, Unit 51767,

Denver, CO 80203 

(Address of principal executive offices) (zip code)

 

516-274-8700

(Registrant’s telephone number, including area code)

 

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock par value $0.0001 per share   AUID   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.

 

Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

 

Yes ☐ No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

 

Class   Outstanding at August 5, 2024
Common Stock, par value $0.0001   10,920,851 shares
Documents incorporated by reference:   None

 

 

 

 

 

TABLE OF CONTENTS

 

    Page No.
PART I – FINANCIAL INFORMATION    
     
Item 1. Financial Statements   1
     
Condensed Consolidated Balance Sheets as of June 30, 2024 (unaudited) and December 31, 2023   1
     
Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2024 and 2023 (unaudited)   2
     
Condensed Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended June 30, 2024 and 2023 (unaudited)   3
     
Condensed Consolidated Statements of Stockholders’ Equity for the Three and Six Months Ended June 30, 2024 and 2023 (unaudited)   4
     
Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2024 and 2023 (unaudited)   5
     
Notes to Unaudited Condensed Consolidated Financial Statements   6–12
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   13–19
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk   19
     
Item 4. Controls and Procedures   19
     
PART II – OTHER INFORMATION    
     
Item 1. Legal Proceedings   20
     
Item 1A. Risk Factors   20
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   20
     
Item 3. Defaults Upon Senior Securities   20
     
Item 4. Mine Safety Disclosures   20
     
Item 5. Other Information   20
     
Item 6. Exhibits   21

 

i

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

 

This report includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “likely,” “aim,” “will,” “would,” “could,” and similar expressions or phrases identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and future events and financial trends that we believe may affect our financial condition, results of operation, business strategy and financial needs.

 

You should read thoroughly this report and the documents that we refer to herein with the understanding that our actual future results may be materially different from and/or worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements including those made in this report, in Part I. Item 1A. Risk Factors also appear in our Annual Report on Form 10-K for the year ended December 31, 2023 and our other filings with the Securities and Exchange Commission. Some examples of risk factors which may affect our business are as follows:

 

  our lack of significant revenues, positive cash flow and history of losses,
     
  market acceptance of our products and competition;
     
  our ability to attract and retain customers for existing and new products;

 

  our ability to effectively maintain and update our technology and product and service portfolio;

 

  our reliance on third party software and developers;

 

  breaches of network or IT security and presentation attacks;

 

  our ability to hire and retain key personnel and additional talent;
     
  our ability to raise capital under acceptable terms;
     
  our ability to maintain listing of our common stock on the Nasdaq Capital Market;
     
  our ability to adequately protect our intellectual property, or the loss of some of our intellectual property rights through costly litigation or administrative proceedings;

 

  our ability to operate in non-US markets;
     
  the impact of the wars in Ukraine and the Middle East;
     
  stock price and market volatility and the risk of securities litigation;
     
  legislation and government regulation; and
     
  general economic conditions, inflation and access to capital.

 

Other sections of this report include additional factors which could adversely impact our business and financial performance. New risk factors emerge from time to time and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Except for our ongoing obligations to disclose material information under the Federal securities laws, we undertake no obligation to release publicly any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events. These forward-looking statements speak only as of the date of this report, and you should not rely on these statements without also considering the risks and uncertainties associated with these statements and our business.

 

OTHER PERTINENT INFORMATION

 

Unless specifically set forth to the contrary, when used in this report the terms “authID” the “Company,” “we,” “our,” “us,” and similar terms refer to authID Inc., a Delaware corporation and its subsidiaries.

 

The information which appears on our website www.authID.ai is not part of this report.

 

ii

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   June 30,   December 31, 
   2024   2023 
   (unaudited)     
ASSETS        
Current Assets:        
Cash  $14,407,393   $10,177,099 
Accounts receivable, net   192,667    91,277 
Deferred contract costs   156,735    157,300 
Other current assets, net   771,755    476,004 
Contract assets   201,610    
-
 
Total current assets   15,730,160    10,901,680 
           
Intangible Assets, net   255,171    327,001 
Goodwill   4,183,232    4,183,232 
Total assets  $20,168,563   $15,411,913 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities:          
Accounts payable and accrued expenses  $998,040   $1,408,965 
Deferred revenue   243,772    131,628 
Commission liability   46,612    124,150 
Accrued severance liability   325,000    
-
 
Convertible debt, net   232,654    
-
 
Total current liabilities   1,846,078    1,664,743 
Non-current Liabilities:          
Convertible debt, net   
-
    224,424 
Accrued severance liability   
-
    325,000 
Total liabilities  $1,846,078   $2,214,167 
           
Commitments and Contingencies (Note 7)   
 
    
 
 
           
Stockholders’ Equity:          
Common stock, $0.0001 par value, 150,000,000 and 250,000,000 shares authorized; 10,920,851 and 9,450,220 shares issued and outstanding as of June 30, 2024 and December 31, 2023 respectively   1,092    945 
Additional paid in capital   184,164,638    172,714,712 
Accumulated deficit   (165,849,353)   (159,530,535)
Accumulated comprehensive income   6,108    12,624 
Total stockholders’ equity   18,322,485    13,197,746 
Total liabilities and stockholders’ equity  $20,168,563   $15,411,913 

 

See notes to condensed consolidated financial statements.

  

1

 

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   Three Months Ended   Six Months Ended 
   June 30,   June 30, 
   2024   2023   2024   2023 
                 
Revenues, net   280,438    37,142    437,816    74,998 
                     
Operating Expenses:                    
General and administrative   2,169,160    2,016,908    4,231,521    2,839,662 
Research and development   1,392,103    703,590    2,597,071    824,228 
Depreciation and amortization   44,004    76,019    87,412    152,036 
Total operating expenses   3,605,267    2,796,517    6,916,004    3,815,926 
                     
Loss from continuing operations   (3,324,829)   (2,759,375)   (6,478,188)   (3,740,928)
                     
Other Income (Expense):                    
Interest expense, net   (10,369)   (282,109)   (23,507)   (1,082,182)
Interest income   73,957    1,160    182,877    1,160 
Loss on debt extinguishment   
-
    (380,741)   
-
    (380,741)
Conversion expense   
-
    (7,476,000)   
-
    (7,476,000)
Other income (expense), net   63,588    (8,137,690)   159,370    (8,937,763)
                     
Loss from continuing operations before income taxes   (3,261,241)   (10,897,065)   (6,318,818)   (12,678,691)
Income tax expense   
-
    (3,255)   
-
    (3,255)
Loss from continuing operations   (3,261,241)   (10,900,320)   (6,318,818)   (12,681,946)
                     
Gain from discontinued operations   
-
    5,694    
-
    3,439 
Gain on sale of discontinued operations   
-
    216,069    
-
    216,069 
Total gain from discontinued operations   
-
    221,763    
-
    219,508 
Net loss  $(3,261,241)  $(10,678,557)  $(6,318,818)  $(12,462,438)
                     
Net Loss Per Share - Basic and Diluted                    
Continuing operations
  $(0.34)  $(2.16)  $(0.67)  $(3.09)
Discontinued operations
   
-
   $0.04    
-
   $0.05 
Weighted Average Shares Outstanding - Basic and Diluted:
   9,501,691    5,046,514    9,475,956    4,108,372 

 

See notes to condensed consolidated financial statements.

 

2

 

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(Unaudited)

 

    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2024     2023     2024     2023  
                         
Net Loss   $ (3,261,241 )   $ (10,678,557 )   $ (6,318,818 )   $ (12,462,438 )
Foreign currency translation loss     (10,594 )     (132,071 )     (6,516 )     (156,137 )
Comprehensive loss   $ (3,271,835 )   $ (10,810,628 )   $ (6,325,334 )   $ (12,618,575 )

 

  

See notes to condensed consolidated financial statements.

 

3

 

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)

 

                   Accumulated     
           Additional       Other     
   Common Stock   Paid-in   Accumulated   Comprehensive     
   Shares   Amount   Capital   Deficit   Income   Total 
Balances, March 31, 2024   9,450,220   $945   $173,437,683   $(162,588,112)  $16,702   $10,867,218 
Stock-based compensation   -    
-
    725,704    
-
    
-
    725,704 
Sale of common stock for cash, net of offering costs   1,464,965    146    10,001,252    
-
    
-
    10,001,398 
Cashless stock option exercise   5,666    1    (1)   
-
    
-
    - 
Net Loss   -    
-
    
-
    (3,261,241)   
-
    (3,261,241)
Foreign currency translation   -    
-
    
-
    
-
    (10,594)   (10,594)
Balances, June 30, 2024   10,920,851   $1,092   $184,164,638   $(165,849,353)  $6,108   $18,322,485 
                               
Balances, December 31, 2023   9,450,220   $945   $172,714,712   $(159,530,535)  $12,624   $13,197,746 
Stock-based compensation   -    
-
    1,448,675    
-
    
-
    1,448,675 
Sale of common stock for cash, net of offering costs   1,464,965    146    10,001,252    
-
    
-
    10,001,398 
Cashless stock option exercise   5,666    1    (1)   
-
    -    - 
Net loss   -    
-
    
-
    (6,318,818)   
-
    (6,318,818)
Foreign currency translation   -    -    
-
    
-
    (6,516)   (6,516)
Balances, June 30, 2024   10,920,851   $1,092   $184,164,638   $(165,849,353)  $6,108   $18,322,485 
                               
Balances, March 31, 2023   3,247,957   $325   $137,881,276   $(141,914,040)  $131,863   $(3,900,576)
Stock-based compensation   -    
-
    1,055,690    
-
    
-
    1,055,690 
Warrants issued for services   -    
-
    438,000    
-
    
-
    438,000 
Shares issued in lieu of interest   43,348    4    165,147    
-
    
-
    165,151 
Conversion of convertible notes into common stock   2,348,347    235    15,331,776    
-
    
-
    15,332,011 
Conversion of credit facility borrowings into common stock   245,634    24    899,976    
-
    
-
    900,000 
Sale of common stock for cash, net of offering costs   1,989,676    198    6,383,443    
-
    
-
    6,383,641 
Net loss   -    
-
    
-
    (10,678,557)   
-
    (10,678,557)
Foreign currency translation   -    
-
    
-
    
-
    (132,071)   (132,071)
Balances, June 30, 2023   7,874,962   $786   $162,155,308   $(152,592,597)  $(208)  $9,563,289 
                               
Balances, December 31, 2022   3,179,789   $318   $140,257,448   $(140,130,159)  $155,929   $283,536 
Stock-based compensation   -    
-
    (1,542,902)   
-
    
-
    (1,542,902)
Warrants issued for services   -    
-
    438,000    
-
    
-
    438,000 
Shares issued in lieu of interest   111,516    11    387,567    
-
    
-
    387,578 
Conversion of convertible notes into common stock   2,348,347    235    15,331,776    
-
    
-
    15,332,011 
Conversion of credit facility borrowings into common stock   245,634    24    899,976    
-
    
-
    900,000 
Sale of common stock for cash, net of offering costs   1,989,676    198    6,383,443    
-
    
-
    6,383,641 
Net loss   -    
-
    
-
    (12,462,438)   
-
    (12,462,438)
Foreign currency translation   -    
-
    
-
    
-
    (156,137)   (156,137)
Balances, June 30, 2023   7,874,962   $786   $162,155,308   $(152,592,597)  $(208)  $9,563,289 

 

See notes to condensed consolidated financial statements.

 

4

 

 

authID INC. AND SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    Six Months Ended  
    June 30,  
    2024     2023  
CASH FLOWS FROM OPERATING ACTIVITIES:            
Net loss   $ (6,318,818 )   $ (12,462,438 )
Adjustments to reconcile net loss with cash flows from operations:                
Stock-based compensation     1,448,675       (1,542,902 )
Depreciation and amortization expense     87,412       152,036  
Amortization of debt discounts and issuance costs     8,230       689,305  
Non-cash recruiting fees     -       438,000  
Shares issued in lieu of interest     -       387,578  
Gain from sale of discontinued operation     -       (216,069 )
Loss on debt extinguishment     -       380,741  
Conversion expense     -       7,476,000  
Changes in operating assets and liabilities:                
Accounts receivable     (101,390 )     219,684  
Deferred contract costs     (76,973 )     -  
Other current assets     (497,379 )     (136,564 )
Accounts payable and accrued expenses     (411,552 )     63,546  
Deferred revenue     112,144       (22,211 )
Other accrued liabilities     -       290,000  
Adjustments relating to discontinued operations     -       110,064  
Net cash flows from operating activities     (5,749,651 )     (4,173,230 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES:                
Purchase of intangible assets     (15,582 )     -  
Net cash flows from investing activities     (15,582 )     -  
                 
CASH FLOWS FROM FINANCING ACTIVITIES:                
Proceeds from sale of common stock, net of offering costs     10,001,398       6,383,641  
Credit facility drawdown, net of issuance costs     -       543,760  
Net cash flows from financing activities     10,001,398       6,927,401  
                 
Effect of Foreign Currencies     (5,871 )     (12,206 )
                 
Net Change in Cash     4,230,294       2,741,965  
Cash, Beginning of the Period     10,177,099       3,237,106  
Cash, Beginning of the Period - Discontinued Operations     -       2,703  
Cash, End of the Period - Discontinued Operations     -       -  
Cash, End of the Period   $ 14,407,393     $ 5,981,773  
                 
Supplemental Disclosure of Cash Flow Information:                
Cash paid for interest   $ 15,276     $ -  
Cash paid for income taxes - discontinued operations   $ -     $ 364  
Cash paid for income taxes   $ -     $ 3,255  
Cash paid for income taxes - discontinued operations   $ -     $ 1,254  
                 
Schedule of Non-cash Investing and Financing Activities:                
Conversion of convertible note payable and accrued interest to common stock   $ -     $ 7,856,011  
Conversion of credit facility borrowings into common stock   $ -     $ 900,000  
Warrants for services with the sale of common stock   $ 877,392     $ 725,889  
Cashless option and warrant exercises   $ 1     $ -  

 

See notes to condensed consolidated financial statements. 

   

5

 

 

authID INC. AND SUBSIDIARIES 

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – BASIS OF PRESENTATION

 

In the opinion of Management, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for future periods or the full year.

 

The condensed consolidated financial statements include the accounts of authID Inc. and its wholly-owned subsidiaries MultiPay S.A.S., ID Solutions, Inc., FIN Holdings Inc., Ipsidy Enterprises Limited and authID Gaming Inc. (collectively the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

 

Going Concern

 

As of June 30, 2024, the Company had an accumulated deficit of approximately $165.8 million. For the three and six months ended June 30, 2024, the Company earned revenue from continuing operations of approximately $0.3 million and $0.4 million, used approximately $2.8 million and $5.7 million to fund its operations, and incurred a net loss of approximately $3.3 million and $6.3 million.

 

The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition, and acquiring new clients to generate revenues and cash flows. In June 2024, the Company raised approximately $10.0 million after expenses from existing and new stockholders through the sale of Common Stock pursuant to a registered direct offering. Going forward, the Company plans to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. Our growth-oriented business plan to offer products to our customers will require continued capital investment and there is no guarantee that such financing will be available, or available on acceptable terms.

  

There is no assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.

 

Reclassification

 

Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, for the three and six months ended June 30, 2023, we reclassified approximately $64,000 and $93,000, respectively, in expenses from research and development expenses to general and administrative expenses.

 

6

 

 

Net Loss per Common Share

 

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and six months ended June 30, 2024 and 2023 because their effect was antidilutive:

 

Security  2024   2023 
         
Convertible notes payable   8,277    8,277 
Warrants   697,446    497,895 
Stock options   1,852,819    1,561,070 
    2,558,542    2,067,242 

  

Revenue Recognition

 

Software License – The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated. Variable fees are typically earned over time based on monthly users, transaction volumes or a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price. Transaction fees are billed monthly and are constrained to transactions incurred within the month.

 

For contracts with minimum annual fees, the Company generally recognizes the amount of revenue ratably over the contract year and records contract assets for the amount in excess of monthly contract billings relating to variable contract consideration. For certain contracts, the Company enters into an agreement which stipulates a minimum annual fee which is generally due at the end of the contract year, in excess of the amount of monthly billings. The Company may also require milestone payments of the minimum annual fee. The amount of any billed fees in excess of revenue recognized is recorded as deferred revenue.

 

Any usage-based fees in excess of the minimum contract amount are charged to the customer and allocated to the annual period in which they are earned under the contract. At the beginning of each annual period in the contract, the Company estimates the variable amounts for the annual period subject to the constrained variable consideration (usage-based fees) and recognizes that amount on a time-elapsed basis over the annual period. At each reporting date within an annual period, the Company reassesses its estimate of the excess variable amounts for the annual period and updates the amount recognized on a time-elapsed basis over the remainder of the annual period.

 

The Company had deferred revenue contract liabilities of approximately $244,000 and $132,000 as of June 30, 2024 and December 31, 2023, respectively, for certain revenue that will be earned in future periods. All deferred revenue contract liabilities as of June 30, 2024 are expected to be earned over the next twelve months.

 

Concentration of Revenue and Accounts Receivable

 

For the six months ended June 30, 2024, two customers represented 59% of revenue, respectively. For the six months ended June 30, 2023, one customer represented 47% of revenue. For the three months ended June 30, 2024, three customers represented 76% of revenue, respectively. For the three months ended June 30, 2023, one customer represented 51% of revenue. As of June 30, 2024, three customers accounted for 80% respectively, of accounts receivable. As of December 31, 2023, two customers accounted for 67%, respectively, of accounts receivable.

 

7

 

 

Remaining Performance Obligations

 

As of June 30, 2024, the Company’s Remaining Performance Obligation (RPO) was $4.24 million, of which $0.24 million is held as deferred revenue and $4.00 million is related to other non-cancellable contracted amounts. The Company expects approximately 36% of the RPO to be recognized as revenue over the next twelve months ending June 30, 2025 based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have sufficient historical information to estimate the recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties.

 

Deferred Contract Costs – We defer the portion of sales commission that is considered a cost of obtaining a new contract with a customer and amortize these deferred costs over the period of benefit. We expense the remaining sales commissions as incurred. The following table summarizes deferred contract cost activity for the six months ended June 30, 2024:

 

   Deferred 
   Contract Costs 
     
Carrying Value at December 31, 2023  $157,300 
Additions   8,294 
Amortization   (8,859)
Carrying Value at June 30, 2024  $156,735 

 

NOTE 2 – OTHER CURRENT ASSETS

 

Other current assets consisted of the following at June 30, 2024 (unaudited) and December 31, 2023:

 

   June 30,   December 31, 
   2024   2023 
         
Prepaid insurance  $310,205   $184,492 
Prepaid third party services   461,550    291,512 
   $771,755   $476,004 

 

NOTE 3 – INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

 

The Company’s intangible assets primarily consist of acquired and developed software that is being amortized over their estimated useful lives as indicated below. The following is a summary of activity related to intangible assets for the six months ended June 30, 2024 (unaudited):

 

   Acquired and         
   Developed         
   Software   Patents   Total 
             
Useful Lives   5 Years    10 Years      
                
Carrying Value at December 31, 2023  $212,798   $114,203   $327,001 
Additions   
-
    15,582    15,582 
Amortization   (78,585)   (8,827)   (87,412)
Carrying Value at June 30, 2024  $134,213   $120,958   $255,171 

  

8

 

 

The following is a summary of intangible assets as of June 30, 2024 (unaudited):

 

   Acquired and         
   Developed         
   Software   Patents   Total 
Cost  $1,734,662   $180,196   $1,914,858 
Accumulated amortization   (1,600,449)   (59,238)   (1,659,687)
Carrying Value at June 30, 2024  $134,213   $120,958   $255,171 

 

Amortization expense totaled approximately $87,000 and $152,000 for the six months ended June 30, 2024, and 2023, respectively.

 

Future expected amortization of intangible assets is as follows:

 

2024 (Remainder of the Year)  $87,595 
2025   70,889 
2026   20,786 
2027   18,019 
2028   18,019 
Thereafter   39,863 
   $255,171 

 

There were no impairment indicators noted with respect to Company’s long-lived assets, including intangible assets, as of June 30, 2024.

 

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consisted of the following as of June 30, 2024 (unaudited) and December 31, 2023:

 

   June 30,   December 31, 
   2024   2023 
         
Trade payables  $248,907   $235,606 
Accrued payroll and related obligations   97,168    707,317 
Insurance Premium Liability   245,542    104,226 
Other accrued expenses   406,423    361,816 
   $998,040   $1,408,965 

  

NOTE 5 – RELATED PARTY TRANSACTIONS

 

Board of Directors

 

On February 15, 2024, Mr. Joe Trelin tendered his resignation as Chairman and a Director of the Company, effective immediately. On February 20, 2024, the board of directors of the Company (the “Board”) accepted his resignation and agreed to vest the unvested portion of an option granted to Mr. Trelin on June 28, 2023, amounting to 6,511 shares.

 

On March 25, 2024, Mr. Kunal Mehta was appointed as a Director of the Company, upon the standard terms for non-employee Directors. On May 20, 2024, Mr. Mehta was granted an option to purchase 13,282 shares of common stock at an exercise price of $7.78 per share. 12,500 of the shares vest annually in equal amounts over a three-year period commencing in 2025 and 782 shares vested monthly in equal amounts over a three-month period commencing March 2024.

 

9

 

 

Commercial Agreements

 

On June 6, 2023, the Company entered into a services agreement with The Pipeline Group, Inc. (“TPG”). Ken Jisser, a director of the Company, is the founder and CEO of TPG, a technology-enabled services company that aims to deliver business results for companies looking to build a predictable and profitable pipeline. As of June 30, 2024, the Company held a balance of approximately $117,000 in prepaid expenses related to this service agreement. In June 2024, the agreement with TPG was renewed for an additional year at a reduced fee rate of $70,000 per month. Total expense incurred under this contract during the three and six months ended June 30, 2024 was approximately $285,000 and $542,000, respectively. Total expense incurred under this contract during the three and six months ended June 30, 2023 was approximately $67,000 and $99,000, respectively.

 

Employment Agreement

 

Since June 2023, the Company has employed Dale Daguro, the brother of our CEO, Rhon Daguro as a VP Sales. Dale Daguro’s employment is at will and may be terminated at any time, with or without cause. On July 12, 2023, Dale was granted an option to purchase 25,000 shares of common stock at an exercise price of $7.36 and on December 21, 2023 he was granted a further option to purchase 4,000 shares of common stock at an exercise price of $9.25 per share. Dale’s compensation is commensurate with other executives employed by the Company at a similar level of seniority and experience. During the six months ended June 30, 2024, Dale Daguro earned approximately $148,000 in base salary and sales commission.

 

Issuance of Common Stock

 

On June 27, 2024, Michael Thompson, a Director of the Company purchased 12,254 shares of the Company’s common stock at an aggregate price of $100,000, as part of the Company’s Registered Direct offering (See Note 6 – Stockholders’ Equity).

 

NOTE 6STOCKHOLDERS’ EQUITY

 

Common Stock

 

On June 27, 2024, pursuant to Securities Purchase Agreements in a Registered Direct Offering, the Company issued 1,464,965 shares of common stock for cash gross proceeds of approximately $11.0 million (or approximately $10.0 million, net of offering costs).

 

During the six months ended June 30, 2024 the Company issued 5,666 shares of common stock, upon the cashless exercise of a stock option.

 

During the six months ended June 30, 2023, shares of common stock were issued as a result of the following transactions:

 

On May 26, 2023, pursuant to Securities Purchase Agreements, the Company issued 1,989,676 shares of common stock for cash gross proceeds of approximately $7.3 million (or approximately $6.4 million, net of offering costs).

 

On May 26, 2023, pursuant to a Securities Purchase Agreement, Mr. Garchik capitalized the outstanding principal balance of $900,000 under the Initial Promissory Note, into 245,634 shares of common stock.

 

On May 26, 2023, pursuant to an exchange agreement with Holders of Convertible Notes payable, the Company issued 2,348,347 shares of common stock in exchange for Convertible Notes in the gross principal amount of approximately $8.9 million (approximately $7.9 million, net of debt issuance costs and discount). In addition, the Company recorded approximately $7.5 million of expense on conversion of convertible notes.

 

The Company issued 111,516 shares of common stock for approximately $388,000 of interest accrued under the Convertible Notes and Credit Facility.

 

10

 

 

Warrants

  

On June 27, 2024, in connection with their placement agent services, the Company issued 102,547 common stock warrants to Madison Global Partners, LLC, with a term of 5 years and an exercise price of $7.50 per share.

 

During the six months ended June 30, 2023, warrants were issued as a result of the following transactions:

 

On May 26, 2023, in connection with their placement agent services, the Company issued 156,712 common stock warrants to Madison Global Partners, LLC, with a term of 5 years and an exercise price of $3.664 per share.

 

On May 12, 2023, in connection with certain recruitment services, the Company issued 187,500 common stock warrants to Madison III, LLC with a term of 5 years and an exercise price of $3.164 per share. 

 

The following is a summary of the Company’s warrant activity for the six months ended June 30, 2024 (unaudited):

 

       Weighted   Weighted 
       Average   Average 
   Number of   Exercise   Remaining 
   Shares   Price   Life 
Outstanding, December 31, 2023   598,267   $11.89    3.9 Years 
Granted   102,547   $7.50    5.0 Years 
Exercised/Cancelled   (3,368)  $21.12    - 
Outstanding, June 30, 2024   697,446   $11.20    3.7 Years 

 

Stock Options

 

During the six months ended June 30, 2024, the Company granted Mr. Kunal Mehta 13,282 options to purchase common stock at an exercise price of $7.78 per share. During the six months ended June 30, 2024, the Company also granted a total of 100,000 options to certain new employees at exercise prices ranging from $9.05 to $9.61 per share.

 

During the six months ended June 30, 2024 the Company agreed to accelerate the vesting of 6,511 options for Mr. Joe Trelin under the terms of his resignation with an exercise price of $5.48 per share. These accelerated options would not otherwise have vested prior to termination of service according to their Service conditions. Therefore, the Company recalculated the fair value of these options as of his resignation date of February 20, 2024 using the Black Scholes method.

  

The Company determined the grant date fair value of options granted for the six months ended June 30, 2024, using the Black Scholes Method, as applicable, with the following assumptions:

 

Expected volatility   122123%
Expected term   5 years
Risk free rate   3.80% - 4.46%
Dividend rate   0.00%

 

Activity related to stock options for the six months ended June 30, 2024 (unaudited), is summarized as follows:

 

   Number
of
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Contractual
Term (Yrs.)
   Aggregate
Intrinsic
Value
 
                 
Outstanding at December 31, 2023   1,796,743   $25.20    6.5   $3,630,733 
Granted   113,282   $9.19    10.0   $15,540 
Exercised   (15,625)  $5.48    
-
   $
-
 
Forfeited/cancelled   (41,581)  $24.88    6.5   $
-
 
Outstanding as of June 30, 2024   1,852,819   $24.43    6.2   $4,583,031 
Exercisable as of June 30, 2024   1,227,820   $29.32    5.1   $2,422,237 

 

11

 

 

The following table summarizes stock option information as of June 30, 2024 (unaudited):  

 

       Weighted     
       Average     
       Contractual     
Exercise Price  Outstanding   Term (Yrs.)   Exercisable 
             
$2.64 – $5.00   342,628    8.8    193,339 
$5.01 – $10.00   651,381    9.1    269,719 
$10.01 – $15.00   43,078    2.4    43,078 
$15.01 – $20.00   252,084    1.3    252,084 
$20.01 – $121.28   563,648    3.8    469,600 
    1,852,819    6.2    1,227,820 

 

During the six months ended June 30, 2024, the Company recognized approximately $1.5 million of stock option-based compensation expense. As of June 30, 2024, there was approximately $1.8 million of unrecognized compensation costs related to stock options outstanding that will be expensed through 2027.

 

On May 24, 2024, the Board of Directors adopted the 2024 Equity Incentive Plan (the “2024 Plan”). On June 26, 2024, the stockholders approved and ratified the 2024 Plan and the allocation of 395,000 shares of Common Stock to the 2024 Plan, in addition to the remaining shares not allocated to awards under the 2021 Equity Incentive Plan and any shares, which become available as a result of the forfeiture, or cancellation of any previous awards. As of June 30, 2024, there were 444,115 shares allocated to and available for issuance of awards under the 2024 Plan but no such awards have yet been granted.

 

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

From time to time the Company is a party to various legal or administrative proceedings arising in the ordinary course of our business. While any litigation contains an element of uncertainty, we have no reason to believe that the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company.

 

Leases

 

The Company has no remaining lease agreements as of July 2023.

  

NOTE 8 – SUBSEQUENT EVENTS

 

In July 2024, the Company evaluated the rollout timelines for several customers who have delayed go-live adoption dates due to their respective corporate processes and timelines. The Company has come to a verbal agreement with one customer (who comprises $1.3 million of the Company’s RPO) to modify the terms of their contract to defer the timing of their minimum payment obligations by approximately 12 months. The Company expects this modification agreement to be finalized during the quarter ending September 30, 2024, resulting in a reduction in the future periodic recognition of the revenue associated with this performance obligation through the end of the initial contract period, December 31, 2027. The proposed modification is not expected to affect the overall RPO associated with this customer’s contract.

 

In August 2024, the Board adopted a new policy on compensation for non-employee directors, which is summarized as follows

 

Each non-employee director will receive:

 

Total annual compensation equal to $125,000, payable in cash and equity.

 

Annual cash compensation of $8,000, or $10,000 if they are a committee chair, payable quarterly in arrear.

 

Annual equity compensation of $117,000 by way of an option grant to purchase common stock. The number of shares which will be the subject of each grant shall be determined by reference to the Black Scholes value of the grant based on the closing price of the common stock, as reported by the NASDAQ Stock Market (or such other principal securities exchange or market system on which the common stock is then listed,) on the date of the Annual Meeting, at which the director is re-elected by the stockholders to serve on the Board. Each stock option shall be a non-qualified stock option with a term of 10 years and shall become fully vested on the first anniversary of the grant date, with equal monthly vesting over a 12 month period, provided that such non-employee director remains as a director of the Company during such 12 month period. Each such option shall have an exercise price equal to the closing price of the common stock, as reported by the NASDAQ Stock Market, on the grant date. The grant date may be deferred in accordance with the Company’s Policy on Granting Equity Awards, if the Annual Meeting is held during a closed trading window.

 

In accordance with this new policy, each non-employee director will receive an option grant of 15,627 shares, on the third day after the announcement of the Company’s results for the period ended June 30, 2024, at an exercise price equal to the closing price of the common stock on the NASDAQ Stock Market on that day.

  

12

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The discussion and analysis of our financial condition and results of operations are based on our financial statements, which we have prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenues and expenses during the reporting periods. On an ongoing basis, we evaluate estimates and judgments, including those described in greater detail below. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

As used in this “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” except where the context otherwise requires, the term “we,” “us,” “our,” “authID” or “the Company,” refers to the business of authID Inc. and its subsidiaries.

 

Overview 

 

authID ensures cyber-savvy enterprises “Know Who’s Behind the Device”TM for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user’s identity, eliminating any assumption of ‘who’ is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric passwordless authentication and account recovery, with a fast, accurate, user-friendly experience – delivering identity verification in 700ms. Establishing a biometric root of trust for each user that is bound to their accounts, or provisioned devices, authID stops fraud at onboarding, eliminates password risks and costs, and provides the faster, frictionless, and more accurate user identity experience demanded by operators of today’s digital ecosystems.

 

Our Platform

 

Our VerifiedTM cloud-based platform was developed with internally developed software as well as acquired and licensed technology and provides the following core services:

 

  Biometric Identity Verification

 

  Biometric Identity Authentication

 

  Account / Access Recovery

 

  FIDO Passkey binding

 

Biometric Identity Verification

 

Biometric identity verification establishes the trusted identity of a user based on a variety of ground truth sources, including government-issued identity documents such as national IDs, driver’s licenses and passports or electronic machine-readable travel documents (or eMRTDs). Our VerifiedTM platform detects presentation attack and spoofing threats, evaluates the authenticity of security features present on a government-issued identity document, and biometrically matches the reference picture of the document with a live user’s selfie (a photograph that the user has taken of themselves). Usually occurring at account opening or onboarding, identity verification ensures that the enterprise knows that the person interacting with the enterprise is who they say they are, in real time. authID’s ProofTM identity verification product eliminates the need for costly and less accurate face-to-face, in-person ID checks and instead provides a verified identity in seconds. In a digital, online world of increasing fraud and security threats, Proof speeds up onboarding and offers our customers confidence in the identities of consumers, employees or third-party vendors.

 

13

 

 

Biometric Identity Authentication

 

Biometric identity authentication provides any organization with a secure, convenient solution to validate that an individual is the verified account owner for various purposes including passwordless login and performing specific transactions, or functions. The authID Verified product allows users to confirm their identity with their facial biometric by simply taking a selfie on a mobile phone or device of their choosing (as opposed to dedicated hardware). The solution includes a patented audit trail created for each transaction, containing the digitally signed transaction details, with proof of identity authentication and consent.

 

Account Access and Recovery

 

authID’s Verified biometric identity authentication solution allows users to recover, via a facial biometric, account access that is lost or blocked due to expired credentials, lockouts, lost or stolen devices, or compromised accounts. Because the account owner’s root of trust is established in the cloud, recovery is independent of any device or hardware. In this way, account recovery is instant, portable, and does not require the presence of or access to a previously provisioned device in order to secure access from a different device.

 

FIDO Passkey Binding

 

FIDO Passkey Binding enables enterprises and their users to bind biometrically verified user identities to FIDO2 passkeys, enabling strong authentication for device-based passwordless login and transaction authentication that is tied to a trusted identity. This solution establishes a digital chain of trust between biometrically verified individuals, their accounts, and their devices, thus eliminating passwords and protecting users and systems against fraud attacks.

 

Key Customer Benefits

 

Our solution allows our enterprise customers to:

 

  Verify and Authenticate users. Customers can use the authID platform not only to verify the identity of new users, but also to authenticate those users seamlessly on an ongoing basis to enable quick, secure logins and transaction authentications.

 

  Benefit from high-speed processing. Our solution returns a very low-latency response, key to enabling high-volume use cases (such as logins and high-value transactions) and providing a frictionless user experience.

 

  Precisely and accurately identify their consumers and employees, giving the enterprise complete confidence in who is accessing their digital assets

 

  Provide a seamless user experience in terms of speed and self-guided flow, so that even users who are not tech-savvy are easily able to complete the identity verification and authentication processes

 

  Support a wide variety of devices. Our cloud-based service is device agnostic and may be used to verify or authenticate users on any device with a camera, including shared devices, digital kiosks, etc.

 

  Integrate quickly and easily. We offer pre-integrated OIDC connections as well as integrations with several leading Identity and Access Management solutions.

 

  Offer broad identity document coverage. We can verify identities using a wide spectrum of government-issued documents from around the world.

 

14

 

  

Key Trends

 

We believe that our financial results will be impacted by several market trends in the identity verification and authentication markets, as well as expanding digital transformation efforts across a wide range of market segments. These trends include:

 

  growing concerns over identity theft, fraud and account takeover, resulting from the acceleration of digital transformation, for example online shopping and remote working and the growth in AI assisted fraud;

 

  the growth in the sharing economy; and

 

  the increase in electronic payments and alternative money transfer solutions provided by both bank and non-bank entities. The key drivers for these alternative payment methods are consumer demands for safe, convenient payment transactions, with less friction.

 

Our results are also impacted by the changes in levels of spending on identity verification, management and security methods, and thus, negative trends in the global economy and other factors which negatively impact such spending may negatively impact the growth in our revenue from those products. The global economy has been undergoing a period of political and economic uncertainty and stock markets are experiencing high levels of volatility, and it is difficult to predict how long this uncertainty and volatility will continue. 

 

We plan to grow our business by increasing the use of our services by our existing customers, by adding new customers through our direct salesforce, channel partners and by expanding into new markets and innovation. If we are successful in these efforts, we would expect our revenue to continue to grow.

 

The Company was incorporated in the State of Delaware on September 21, 2011, and changed our name from Ipsidy Inc. to authID Inc. on July 18, 2022. Our corporate headquarters is located at 1580 North Logan Street, Suite 660, Unit 51767, Denver, CO 80203 and our main phone number is (516) 274-8700. Our website address is www.authid.ai. The information contained on, or that can be accessed through, our website is not incorporated by reference into this Form 10-Q and you should not consider information on our website to be part of this Form 10-Q.

 

Going Concern

 

The Company’s unaudited condensed consolidated financial statements included in this Quarterly Report have been prepared in accordance with United States GAAP assuming the Company will continue on a going concern basis, which implies the Company will continue to meet its obligations and continue its operations for the next year following the issuance date of these financial statements.

 

15

 

 

As of June 30, 2024, the Company had an accumulated deficit of approximately $165.8 million. For the six months ended June 30, 2024, the Company earned revenue from continuing operations of approximately $0.4 million, used approximately $5.7 million to fund its operations, and incurred a net loss of approximately $6.3 million. The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders and noteholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition and /or acquiring new clients to generate revenues and cash flows. In June 2024, the Company raised approximately $10.0 million after expenses from existing and new stockholders through the sale of Common Stock pursuant to a registered direct offering. Going forward, the Company plans to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. Our growth-oriented business plan to offer products to our customers will require continued capital investment and there is no guarantee that such financing will be available, or available on acceptable terms.

  

There is no assurance that the Company will ever be profitable. These consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow profitable) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.  

 

Adjusted EBITDA

 

This discussion includes information about Adjusted EBITDA that is not prepared in accordance with GAAP. Adjusted EBITDA is not based on any standardized methodology prescribed by GAAP and is not necessarily comparable to similar measures presented by other companies. A reconciliation of this non-GAAP measure is included below. Adjusted EBITDA is a non-GAAP financial measure that represents GAAP net income (loss) adjusted to exclude (1) interest expense and debt discount and debt issuance costs amortization expense, (2) interest income, (3) provision for income taxes, (4) depreciation and amortization, (5) stock-based compensation expense (stock options) and (6) loss on debt extinguishment, and conversion expense on exchange of Convertible Notes and certain other items management believes affect the comparability of operating results. Management believes that Adjusted EBITDA, when viewed with our results under GAAP and the accompanying reconciliations, provides useful information about our period-over-period results. Adjusted EBITDA is presented because management believes it provides additional information with respect to the performance of our fundamental business activities and is also frequently used by securities analysts, investors and other interested parties in the evaluation of comparable companies. We also rely on Adjusted EBITDA as a primary measure to review and assess the operating performance of our company and our management, and it will be a focus as we invest in and grow the business. Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation from, or as a substitute for, analysis of our results as reported under GAAP. Some of these limitations are:

 

  Adjusted EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments;

 

  Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

 

  Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;

 

  Adjusted EBITDA does not include the impact of certain charges or gains resulting from matters we consider not to be indicative of our ongoing operations.

 

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only as a supplement to our GAAP results.

 

16

 

 

Reconciliation of Loss from Continuing Operations to Adjusted EBITDA Continuing Operations:

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2024   2023   2024   2023 
                 
Loss from continuing operations  $(3,261,241)  $(10,900,320)  $(6,318,818)  $(12,681,946)
                     
Addback:                    
                     
Interest expense, net   10,369    282,109    23,507    1,082,182 
Other income   (73,957)   (1,160)   (182,877)   (1,160)
Loss on debt extinguishment   -    380,741    -    380,741 
Conversion expense   -    7,476,000    -    7,476,000 
Severance cost   8,638    17,917    14,251    828,958 
Depreciation and amortization   44,004    76,019    87,412    152,036 
Non-cash recruiting fees   -    (54,000)   -    438,000 
Taxes   -    3,255    -    3,255 
Stock compensation   725,704    1,055,690    1,448,675    (1,542,902)
Adjusted EBITDA continuing operations (Non-GAAP)  $(2,546,483)   (1,663,749)   (4,927,850)   (3,864,836)

 

Three and Six Months Ended June 30, 2024 and June 30, 2023 – Continuing Operations

 

Revenues, net

 

During the three and six months ended June 30, 2024, the Company’s revenues were approximately $280,000 and $438,000, respectively, compared to approximately $37,000 and $75,000, respectively, in the three and six months ended June 30, 2023, principally due to the recognition of revenue from new customer contracts signed in the 2nd half of 2023.

 

General and administrative expenses

 

During the three and six months ended June 30, 2024 compared to the three and six months ended June 30, 2023, general and administrative expense increased by approximately $0.2 million and $1.4 million, respectively. The increase for the six months period was comprised of a one-time event, representing an approximately $2.5 million reversal of stock-based compensation in Q1 2023 on stock awards with market vesting conditions resulting from Q1 2023 terminations, which was not repeated in 2024 and an approximately $1.1 million reduction in expense due to cost savings from the 2023 restructuring initiative.

 

Research and development expenses

 

During the three and six months ended June 30, 2024 compared to the three and six months ended June 30, 2023, research and development expenses increased by approximately $0.7 million and $1.8 million, respectively. The increase was comprised of re-investment in employees and contractors following the 2023 restructuring as well as $0.8 million from the one-time reversal of stock-based compensation in Q1 2023 on stock awards with market vesting conditions resulting from Q1 2023 terminations, which was not repeated in 2024.

 

Depreciation and amortization expense

 

During the three and six months ended June 30, 2024 compared to June 30, 2023, depreciation and amortization expense was approximately $0.03 million and $0.06 million less, respectively, as the Company reduced the value of certain legacy business asset values.

 

17

 

 

Interest expense, net

 

Interest expense, net includes interest expense, debt issuance and discount amortization expense. Interest expense decreased by approximately $0.3 million and $1.1 million during the three and six months ended June 30, 2024 compared to June 30, 2023 principally due to the exchange of Convertible Notes for common stock in May 2023.

 

Three and Six Months Ended June 30, 2024 and June 30, 2023 – Discontinued Operations

 

On May 4, 2022, the Board approved a plan to exit from certain non-core activities comprising the MultiPay correspondent bank, payments services in Colombia.

 

MultiPay business in Colombia

 

In June 2023, MultiPay finalized the sale of the Company’s proprietary software to its major customer for approximately $96,000. As a result, the Company recognized a gain of approximately $216,000 which included the release of a foreign currency translation gain of approximately $155,000.

 

Although the Company exited the MultiPay business in Colombia, it still maintains an authID customer support and operations team in Bogota which performs essential functions to support the global operations of our Verified and Proof products.

 

Liquidity and Capital Resources

 

The Company has approximately $14.4 million of cash on hand and approximately $13.9 million of working capital as of June 30, 2024.

 

Cash used in operating activities was approximately $5.7 million and $4.2 million in the six months ended June 30, 2024 and 2023, respectively.

 

Cash used in investing activities for the six months ended June 30, 2024 was approximately $16,000, compared with $0 for six months ended June 30, 2023, for the payment of patent costs.

 

Cash provided by financing activities in the six months ended June 30, 2024 consisted of approximately $10.0 million in proceeds from the sale of common stock, net of offering costs.

 

Cash provided by financing activities in the six months ended June 30, 2023 consisted of approximately $6.4 million in proceeds from the sale of common stock, net of offering costs, and $0.5 million initial drawdown net of debt issuance costs under the Company’s A&R Facility Agreement.

  

In 2025, the Company will need to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. Our growth-oriented business plan to offer products to our customers will require continued capital investment and there is no guarantee that such financing will be available, or available on acceptable terms.

 

There is no guarantee that our current business plan will not change, and as a result of such change, we will need additional capital to implement such business plan. Further, assuming we achieve our expected growth plan, of which there is no guarantee, we will need additional capital to implement growth beyond our current business plan. 

 

Ukraine and the Middle East

 

The war in Ukraine and the Middle East may impact the Company and its operations in a number of different ways, which are yet to be fully assessed and are therefore uncertain. The Company’s principal concern is for the safety of the personnel who support us from those regions. The Company works with third party sub-contractors for outsourced services, including software engineering and development, some of whom are based in Eastern Europe. The Company also works with outsourced engineers and developers and third-party providers in other parts of the world, including the United States, Europe, India, and Latin America. While the continuing impact of this conflict and the response of the United States and other countries to it by means of trade and economic sanctions, or other actions is still unknown, it could disrupt our ability to work with certain contractors. The Company has taken steps to diversify its sub-contractor base, which may in the short term give rise to additional costs and delays in delivering software and product upgrades.

 

18

 

 

The uncertainty impacting and potential interruption in energy and other supply chains resulting from military hostilities in Europe and the Middle East and the response of the United States and other countries to it by means of trade and economic sanctions, or other actions, may give rise to increases in costs of goods and services generally and may impact the market for our products as prospective customers reconsider additional capital expenditure, or other investment plans until the situation becomes clearer. On the other hand, the threat of increased cyber-attacks from multiple threat actors, including state-sponsored organizations may prompt enterprises to adopt additional security measures such as those offered by the Company.

 

For so long as the hostilities continue and perhaps even thereafter as the situation in Europe and the Middle East unfolds, we may see increased volatility in financial markets and a flight to safety by investors, which may impact our stock price and make it more difficult for the Company to raise additional capital at the time when it needs to do so, or for financing to be available upon acceptable terms. All or any of these risks separately, or in combination could have a material adverse effect on our business, financial condition, results of operations, and cash flows.

 

Off-Balance Sheet Arrangements

 

The Company has no off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is deemed by our management to be material to investors.

 

Recent Accounting Policies

 

The recent material accounting policies that may be the most critical to understanding of the financial results and conditions are discussed in Note 1 of the unaudited financial statements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

As a smaller reporting company, we are not required to include disclosure under this item.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this Quarterly Report, our Chief Executive Officer and Chief Financial Officer performed an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2024, the Company’s disclosure controls and procedures are effective to ensure that the information required to be disclosed by the Company in the report that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as that term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the six months ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

19

 

 

PART II

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, the Company is a party to various legal or administrative proceedings arising in the ordinary course of business. While any litigation contains an element of uncertainty, we have no reason to believe the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company.

 

ITEM 1A. RISK FACTORS

 

Risk factors describing the major risks to our business can be found under Item 1A, “Risk Factors”, in our Annual Report on Form 10-K for the year ended December 31, 2023. There has been no material change in our risk factors from those previously discussed in the Annual Report on Form 10-K.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

   

During the six months ended June 30, 2024, the Company granted a total of 100,000 options to certain new employees at exercise prices ranging from $9.05 to $9.61 per share.

 

Mr. Mehta, a director of the Company, was granted an option to purchase 13,282 shares of common stock at an exercise price of $7.78 per share. 12,500 of the shares vest annually in equal amounts over a three-year period commencing in 2025 and 782 shares vested monthly in equal amounts over a three-month period commencing March 2024.

 

The Company issued 5,666 shares of common stock in connection with the cashless exercise of stock options by employees.

 

The issuance of the above securities is exempt from the registration requirements under Rule 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 as promulgated under Regulation D.

  

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable to our operations.

 

ITEM 5. OTHER INFORMATION

 

Retirement of Joseph Trelin and Appointment of Kunal Metha

 

On February 15, 2024, Mr. Joe Trelin tendered his resignation as Chairman and a Director of the Company, effective immediately. On February 20, 2024, the Board of Directors of the Company accepted his resignation and agreed to vest the unvested portion of an option granted to Mr. Trelin June 28, 2023, amounting to 6,511 shares.

 

On March 25, 2024, Kunal Mehta was appointed as an independent member of the Board of Directors of the Company. Mr. Mehta entered into a letter agreement with the Company upon standard terms for non-employee directors. Mr. Mehta was granted an option to purchase 13,282 shares of common stock at an exercise price of $7.78 per share. 12,500 of the shares vest annually in equal amounts over a three-year period commencing in 2025 and 782 shares vested monthly in equal amounts over a three-month period commencing March 2024.

 

Amendment of Certificate of Incorporation.

 

On June 26, 2024, the Company filed an amendment to its Certificate of Incorporation with the Delaware Secretary of State which reduced the number of shares of Common Stock, which the Company is authorized to issue from 250,000,000 to 150,000,000.

 

20

 

 

ITEM 6. EXHIBITS 

 

Exhibit
Number
  Description
3.1 (1)   Amended & Restated Certificate of Incorporation
3.2 (14)   Amended & Restated Bylaws as of July 18, 2022
3.3 (2)   Certificate of Amendment dated June 1, 2021
3.4 (14)   Certificate of Amendment to Amended and Restated Certificate of Incorporation as of July 18, 2022
3.5 (15)   Certificate of Amendment to Amended and Restated Certificate of Incorporation as of September 21, 2022
3.6 (23)   Certificate of Amendment to the Amended and Restated Certificate of Incorporation dated June 26, 2023
3.7(31)   Certificate of Amendment to the Certificate of Incorporation
4.1 (2)   Form of Stock Option
4.2 (3)   Form of 8.0% Convertible Note
4.3 (4)   Form of 15.0% Convertible Note
4.4 (4)   Amended and Restated Promissory Note issued to The Theodore Stern Revocable Trust
4.5 (5)   Paycheck Protection Program Term Note dated May 6, 2020
4.6 (6)   Paycheck Protection Program Term Note dated February 1, 2021
4.7 (18)   Description of the Registrant’s Securities
10.1 (2)   Form of Director Agreement
10.2 (2)   Form of Indemnification Agreement
10.5 (7)   2017 Incentive Stock Plan
10.7 (2)   Executive Retention Agreement entered between the Company and Thomas L. Thimot dated June 14, 2021
10.8 (2)   Executive Retention Agreement entered between the Company and Cecil N. Smith III dated June 14, 2021
10.9 (2)   Letter Agreement between the Company and Thomas L. Thimot dated June 14, 2021
10.10 (2)   Letter Agreement between the Company and Cecil N. Smith III dated June 14, 2021
10.11 (8)   Letter Agreement between the Company and Phillip L. Kumnick dated as November 5, 2021
10.12 (8)   Letter Agreement between the Company and Philip R. Broenniman dated as November 5, 2021
10.13 (9)   AuthID Inc. 2021 Equity Incentive Plan
10.14 (11)   Letter Agreement between AuthID Inc. and Thomas Szoke dated November 19, 2021
10.15 (10)   Form of Securities Purchase Agreement entered into between the Company and the Note Investors dated March 21, 2022.
10.16 (10)   Form of Senior Secured Convertible Note issued by the Company to the Note Investors dated March 21, 2022.
10.17 (10)   Security and Pledge Agreement entered into between the Company and Stephen J. Garchik as Collateral Agent dated March 21, 2022.
10.19 (10)   Form of Registration Rights Agreement entered into between the Company and the Note Investors dated March 21, 2022.
10.20 (10)   Facility Agreement entered into between the Company and Stephen J. Garchik dated March 21, 2022.
10.21 (10)   Form of Subscription Agreement entered into between the Company and the PIPE Investors dated March 21, 2022.
10.22 (12)   Letter Agreement between Joseph Trelin and AuthID Inc. dated April 18, 2022
10.23 (13)   Letter Agreement between Annie Pham and AuthID Inc. dated April 25, 2022
10.24 (16)   Amended and Restated Facility Agreement between the Company and Stephen J. Garchik dated March 8, 2023.
10.25 (16)   Promissory Note between the Company and Stephen J. Garchik dated March 9, 2023.
10.26 (16)   Guaranty Agreement by FIN Holdings Inc., Innovation in Motion, Inc. and ID Solutions, Inc. in favor of Stephen J. Garchik dated March 9, 2023.

 

21

 

 

10.27 (16)   Release Agreement between the Company and Stephen J. Garchik dated March 9, 2023.
10.28 (17)   Letter Agreement between Rhoniel Daguro and AuthID Inc. dated March 23, 2023
10.29 (17)   Executive Retention Agreement between Rhoniel Daguro and AuthID Inc. dated March 23, 2023
10.30 (17)   Confidential Separation Agreement and General Release between Thomas Thimot and authID Inc. Dated March 23, 2023
10.31 (19)   Letter Agreement between Thomas Szoke and AuthID Inc. dated April 12, 2023
10.32 (19)   Executive Retention Agreement between Thomas Szoke and AuthID Inc. dated April 12, 2023
10.33 (21)   Executive Retention Agreement between Annie Pham and AuthID Inc. dated May 11, 2023
10.34 (22)**   Form of Securities Purchase Agreement dated as of May 23, 2023 between the Company and accredited investors
10.35 (22)   Engagement Agreement dated as of April 20, 2023 between the Company and Madison Global Partners LLC
10.36 (22)   Stock Purchase Warrant dated May 26, 2023 issued to Madison Global Partners LLC
10.37 (22)**   Form of Exchange Agreement dated as of May 23, 2023 between the Company and certain Holders
10.38 (24)   Letter Agreement between Edward Sellitto and authID Inc. dated July 31, 2023
10.39 (25)   Agreement dated October 25, 2023 between The Pipeline Group, Inc. and authID Inc.
10.40 (27)   Form of Securities Purchase Agreement dated as of November 20, 2023 between the Company and accredited investor
10.41 (27)   Engagement Agreement dated as of November 2, 2023 between the Company and Madison Global Partners, LLC
10.42 (27)   Stock Purchase Warrant dated November 22, 2023 issued to Madison Global Partners, LLC
10.42 (28)**   Agreement dated December 19, 2023 between The Pipeline Group, Inc and authID Inc.
10.43 (29)   Letter Agreement between Kunal Mehta and authID Inc.
10.44(31)**   Form of Securities Purchase Agreement dated as of June 24, 2024 between the Company and accredited investors
10.45(31)   Engagement Agreement, dated as of June 24, 2024 between the Company and Madison Global Partners, LLC
10.46(31)   Stock Purchase Warrant issued to Madison Global Partners LLC
14.1 (26)   Code of Ethics
21.1 (20)   List of Subsidiaries
31.1*   Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act
31.2*   Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act
32.1*   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
97.1 (26)   Policy for the Recovery of Erroneously Awarded Compensation adopted October 6, 2023
99.1 (30)   Policy on Granting Equity Awards
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

  

*Filed herewith

 

**Certain confidential portions of this exhibit were omitted by means of marking such portions with asterisks because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed. A copy of any omitted portions will be furnished to the SEC upon request.

 

(1) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 23, 2021.
(2) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on June 15, 2021.
(3) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on December 16, 2019.
(4) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on February 18, 2020.
(5) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on May 13, 2020.

 

22

 

 

(6) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on May 6, 2021.
(7) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on May 4, 2018.
(8) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on November 8, 2021.
(9) Incorporated by reference to the Form S-8 Registration Statement filed with the Securities Exchange Commission on February 1, 2022.
(10) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 21, 2022.
(11) Incorporated by reference to the Form 10-K Annual Report filed with the Securities Exchange Commission on March 22, 2022.
(12) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 18, 2022.
(13) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 27, 2022.
(14) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on July 19, 2022.
(15) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on September 21, 2022.
(16) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 10, 2023.
(17) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 28, 2023.
(18) Incorporated by reference to the Form 10-K Annual Report filed with the Securities Exchange Commission on March 30, 2023.
(19) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on April 18, 2023.
(20) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on May 11, 2023.
(21) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on May 16, 2023.
(22) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on May 26, 2023.
(23) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on June 27, 2023.
(24) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on August 3, 2023.
(25) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on October 26, 2023.
(26) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on November 8, 2023.
(27) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on November 27, 2023.
(28) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on December 21, 2023.
(29) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on March 26, 2024.
(30) Incorporated by reference to the Form 10-Q Quarterly Report filed with the Securities Exchange Commission on May 15, 2024.
(31) Incorporated by reference to the Form 8-K Current Report filed with the Securities Exchange Commission on June 27, 2024.

 

23

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  authID Inc.

 

  By: /s/ Rhoniel Daguro
    Rhoniel A. Daguro
    Chief Executive Officer
    (Principal Executive Officer)
     
  By: /s/ Ed Sellitto
    Ed Sellitto
    Chief Financial Officer,
    (Principal Financial and Accounting Officer)
Dated: August 8, 2024    

 

 

24

 

 

0.34 0.67 2.16 3.09 0.04 0.05 4108372 5046514 9475956 9501691 false --12-31 Q2 0001534154 0001534154 2024-01-01 2024-06-30 0001534154 2024-08-05 0001534154 2024-06-30 0001534154 2023-12-31 0001534154 2024-04-01 2024-06-30 0001534154 2023-04-01 2023-06-30 0001534154 2023-01-01 2023-06-30 0001534154 us-gaap:CommonStockMember 2024-03-31 0001534154 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001534154 us-gaap:RetainedEarningsMember 2024-03-31 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001534154 2024-03-31 0001534154 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001534154 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001534154 us-gaap:CommonStockMember 2024-06-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001534154 us-gaap:RetainedEarningsMember 2024-06-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001534154 us-gaap:CommonStockMember 2023-12-31 0001534154 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001534154 us-gaap:RetainedEarningsMember 2023-12-31 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001534154 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001534154 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0001534154 us-gaap:CommonStockMember 2023-03-31 0001534154 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001534154 us-gaap:RetainedEarningsMember 2023-03-31 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001534154 2023-03-31 0001534154 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001534154 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001534154 us-gaap:CommonStockMember 2023-06-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001534154 us-gaap:RetainedEarningsMember 2023-06-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001534154 2023-06-30 0001534154 us-gaap:CommonStockMember 2022-12-31 0001534154 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001534154 us-gaap:RetainedEarningsMember 2022-12-31 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001534154 2022-12-31 0001534154 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0001534154 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001534154 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0001534154 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001534154 auid:ThreeCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001534154 auid:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0001534154 auid:ThreeCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-04-01 2024-06-30 0001534154 auid:OneCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-04-01 2023-06-30 0001534154 auid:OneCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-06-30 0001534154 auid:OneCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001534154 us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-06-30 0001534154 us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-06-30 0001534154 us-gaap:WarrantMember 2024-01-01 2024-06-30 0001534154 us-gaap:WarrantMember 2023-01-01 2023-06-30 0001534154 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0001534154 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001534154 us-gaap:FiniteLivedIntangibleAssetsMember 2024-01-01 2024-06-30 0001534154 us-gaap:FiniteLivedIntangibleAssetsMember 2023-01-01 2023-06-30 0001534154 auid:AcquiredAndDevelopedSoftwareMember 2024-06-30 0001534154 us-gaap:PatentsMember 2024-06-30 0001534154 auid:AcquiredAndDevelopedSoftwareMember 2023-12-31 0001534154 us-gaap:PatentsMember 2023-12-31 0001534154 auid:AcquiredAndDevelopedSoftwareMember 2024-01-01 2024-06-30 0001534154 us-gaap:PatentsMember 2024-01-01 2024-06-30 0001534154 srt:BoardOfDirectorsChairmanMember 2023-06-28 2023-06-28 0001534154 srt:DirectorMember 2024-05-20 2024-05-20 0001534154 2024-05-20 0001534154 2024-01-01 2024-03-31 0001534154 2023-07-12 2023-07-12 0001534154 2023-07-12 0001534154 2023-12-21 2023-12-21 0001534154 2023-12-21 0001534154 2024-06-27 2024-06-27 0001534154 2024-06-27 0001534154 2023-05-26 2023-05-26 0001534154 2023-05-26 0001534154 auid:ConvertibleNotePayableMember 2023-05-26 2023-05-26 0001534154 us-gaap:WarrantMember 2024-06-27 0001534154 us-gaap:WarrantMember 2023-05-26 0001534154 us-gaap:WarrantMember 2023-05-12 0001534154 us-gaap:StockOptionMember auid:MrKunalMehtaMember 2024-01-01 2024-06-30 0001534154 us-gaap:StockOptionMember 2024-06-30 0001534154 srt:MinimumMember us-gaap:StockOptionMember 2024-01-01 2024-06-30 0001534154 srt:MaximumMember us-gaap:StockOptionMember 2024-01-01 2024-06-30 0001534154 us-gaap:StockOptionMember auid:MrJoeTrelinMember 2024-01-01 2024-06-30 0001534154 auid:StockOptionsMember 2024-01-01 2024-06-30 0001534154 auid:StockOptionsMember 2024-06-30 0001534154 2024-06-26 0001534154 us-gaap:WarrantMember 2023-12-31 0001534154 us-gaap:WarrantMember 2023-12-31 2023-12-31 0001534154 us-gaap:WarrantMember 2024-01-01 2024-06-30 0001534154 us-gaap:WarrantMember 2024-06-30 0001534154 srt:MinimumMember 2024-01-01 2024-06-30 0001534154 srt:MaximumMember 2024-01-01 2024-06-30 0001534154 2023-12-31 2023-12-31 0001534154 auid:TwoPointSixFourToFivePointZeroZeroMember 2024-06-30 0001534154 auid:TwoPointSixFourToFivePointZeroZeroMember 2024-01-01 2024-06-30 0001534154 auid:FivePointZeroOneToTenPointZeroZeroMember 2024-06-30 0001534154 auid:FivePointZeroOneToTenPointZeroZeroMember 2024-01-01 2024-06-30 0001534154 auid:TenPointZeroOneToFifteenPointZeroZeroMember 2024-06-30 0001534154 auid:TenPointZeroOneToFifteenPointZeroZeroMember 2024-01-01 2024-06-30 0001534154 auid:FifteenPointZeroOneToTwentyPointZeroZeroMember 2024-06-30 0001534154 auid:FifteenPointZeroOneToTwentyPointZeroZeroMember 2024-01-01 2024-06-30 0001534154 auid:TwentyPointZeroOneToOneHundredTwentyOnePointTwoEightMember 2024-06-30 0001534154 auid:TwentyPointZeroOneToOneHundredTwentyOnePointTwoEightMember 2024-01-01 2024-06-30 0001534154 auid:RemainingPerformanceObligationMember us-gaap:SubsequentEventMember 2024-07-31 2024-07-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

 

I, Rhoniel Daguro, Chief Executive Officer certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of authID Inc;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial data information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: August 8, 2024 /s/ Rhoniel Daguro
  Rhoniel Daguro
 

Chief Executive Officer

(Principal Executive Officer)

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER
PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

 

I, Edward Sellitto Chief Financial Officer, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of authID Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant) and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial data information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: August 8, 2024 /s/ Ed Sellitto
  Ed Sellitto
 

Chief Financial Officer

(Principal Financial and Accounting Officer)

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of authID Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2024 as filed with the Securities and Exchange Commission (the “Report”), I, Rhoniel Daguro, Chief Executive Officer of the Company, and, Edward Sellitto, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

August 8, 2024 /s/ Rhoniel Daguro
 

Rhoniel Daguro

Chief Executive Officer

  (Principal Executive Officer)

 

August 8, 2024 /s/ Ed Sellitto
  Ed Sellitto, Chief Financial Officer
  (Principal Financial and Accounting Officer)

 

v3.24.2.u1
Cover - shares
6 Months Ended
Jun. 30, 2024
Aug. 05, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Jun. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Entity Information [Line Items]    
Entity Registrant Name authID Inc.  
Entity Central Index Key 0001534154  
Entity File Number 001-40747  
Entity Tax Identification Number 46-2069547  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period true  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 1580 North Logan Street  
Entity Address, Address Line Two Suite 660, Unit 51767  
Entity Address, City or Town Denver  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80203  
Entity Phone Fax Numbers [Line Items]    
City Area Code 516  
Local Phone Number 274-8700  
Entity Listings [Line Items]    
Title of 12(b) Security Common Stock par value $0.0001 per share  
Trading Symbol AUID  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding   10,920,851
v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash $ 14,407,393 $ 10,177,099
Accounts receivable, net 192,667 91,277
Deferred contract costs 156,735 157,300
Other current assets, net 771,755 476,004
Contract assets 201,610
Total current assets 15,730,160 10,901,680
Intangible Assets, net 255,171 327,001
Goodwill 4,183,232 4,183,232
Total assets 20,168,563 15,411,913
Current Liabilities:    
Accounts payable and accrued expenses 998,040 1,408,965
Deferred revenue 243,772 131,628
Commission liability 46,612 124,150
Accrued severance liability 325,000
Convertible debt, net 232,654
Total current liabilities 1,846,078 1,664,743
Non-current Liabilities:    
Convertible debt, net 224,424
Accrued severance liability 325,000
Total liabilities 1,846,078 2,214,167
Commitments and Contingencies (Note 7)
Stockholders’ Equity:    
Common stock, $0.0001 par value, 150,000,000 and 250,000,000 shares authorized; 10,920,851 and 9,450,220 shares issued and outstanding as of June 30, 2024 and December 31, 2023 respectively 1,092 945
Additional paid in capital 184,164,638 172,714,712
Accumulated deficit (165,849,353) (159,530,535)
Accumulated comprehensive income 6,108 12,624
Total stockholders’ equity 18,322,485 13,197,746
Total liabilities and stockholders’ equity $ 20,168,563 $ 15,411,913
v3.24.2.u1
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Jun. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 150,000,000 250,000,000
Common stock, shares issued 10,920,851 9,450,220
Common stock, shares outstanding 10,920,851 9,450,220
v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenues, net $ 280,438 $ 37,142 $ 437,816 $ 74,998
Operating Expenses:        
General and administrative 2,169,160 2,016,908 4,231,521 2,839,662
Research and development 1,392,103 703,590 2,597,071 824,228
Depreciation and amortization 44,004 76,019 87,412 152,036
Total operating expenses 3,605,267 2,796,517 6,916,004 3,815,926
Loss from continuing operations (3,324,829) (2,759,375) (6,478,188) (3,740,928)
Other Income (Expense):        
Interest expense, net (10,369) (282,109) (23,507) (1,082,182)
Interest income 73,957 1,160 182,877 1,160
Loss on debt extinguishment (380,741) (380,741)
Conversion expense (7,476,000) (7,476,000)
Other income (expense), net 63,588 (8,137,690) 159,370 (8,937,763)
Loss from continuing operations before income taxes (3,261,241) (10,897,065) (6,318,818) (12,678,691)
Income tax expense (3,255) (3,255)
Loss from continuing operations (3,261,241) (10,900,320) (6,318,818) (12,681,946)
Gain from discontinued operations 5,694 3,439
Gain on sale of discontinued operations 216,069 216,069
Total gain from discontinued operations 221,763 219,508
Net loss $ (3,261,241) $ (10,678,557) $ (6,318,818) $ (12,462,438)
Net Loss Per Share - Basic and Diluted        
Continuing operations, Basic (in Dollars per share) $ (0.34) $ (2.16) $ (0.67) $ (3.09)
Discontinued operations, Basic (in Dollars per share) $ 0.04 $ 0.05
Weighted Average Shares Outstanding - Basic (in Shares) 9,501,691 5,046,514 9,475,956 4,108,372
v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Continuing operations, Diluted $ (0.34) $ (2.16) $ (0.67) $ (3.09)
Discontinued operations, Diluted $ 0.04 $ 0.05
Weighted Average Shares Outstanding – Diluted (in Shares) 9,501,691 5,046,514 9,475,956 4,108,372
v3.24.2.u1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net Loss $ (3,261,241) $ (10,678,557) $ (6,318,818) $ (12,462,438)
Foreign currency translation loss (10,594) (132,071) (6,516) (156,137)
Comprehensive loss $ (3,271,835) $ (10,810,628) $ (6,325,334) $ (12,618,575)
v3.24.2.u1
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balance at Dec. 31, 2022 $ 318 $ 140,257,448 $ (140,130,159) $ 155,929 $ 283,536
Balance (in Shares) at Dec. 31, 2022 3,179,789        
Stock-based compensation (1,542,902) (1,542,902)
Warrants issued for services 438,000 438,000
Shares issued in lieu of interest $ 11 387,567 387,578
Shares issued in lieu of interest (in Shares) 111,516        
Conversion of convertible notes into common stock $ 235 15,331,776 15,332,011
Conversion of convertible notes into common stock (in Shares) 2,348,347        
Conversion of credit facility borrowings into common stock $ 24 899,976 900,000
Conversion of credit facility borrowings into common stock (in Shares) 245,634        
Sale of common stock for cash, net of offering costs $ 198 6,383,443 6,383,641
Sale of common stock for cash, net of offering costs (in Shares) 1,989,676        
Net Loss (12,462,438) (12,462,438)
Foreign currency translation (156,137) (156,137)
Balance at Jun. 30, 2023 $ 786 162,155,308 (152,592,597) (208) 9,563,289
Balance (in Shares) at Jun. 30, 2023 7,874,962        
Balance at Mar. 31, 2023 $ 325 137,881,276 (141,914,040) 131,863 (3,900,576)
Balance (in Shares) at Mar. 31, 2023 3,247,957        
Stock-based compensation 1,055,690 1,055,690
Warrants issued for services 438,000 438,000
Shares issued in lieu of interest $ 4 165,147 165,151
Shares issued in lieu of interest (in Shares) 43,348        
Conversion of convertible notes into common stock $ 235 15,331,776 15,332,011
Conversion of convertible notes into common stock (in Shares) 2,348,347        
Conversion of credit facility borrowings into common stock $ 24 899,976 900,000
Conversion of credit facility borrowings into common stock (in Shares) 245,634        
Sale of common stock for cash, net of offering costs $ 198 6,383,443 6,383,641
Sale of common stock for cash, net of offering costs (in Shares) 1,989,676        
Net Loss (10,678,557) (10,678,557)
Foreign currency translation (132,071) (132,071)
Balance at Jun. 30, 2023 $ 786 162,155,308 (152,592,597) (208) 9,563,289
Balance (in Shares) at Jun. 30, 2023 7,874,962        
Balance at Dec. 31, 2023 $ 945 172,714,712 (159,530,535) 12,624 $ 13,197,746
Balance (in Shares) at Dec. 31, 2023 9,450,220       9,450,220
Stock-based compensation 1,448,675 $ 1,448,675
Conversion of credit facility borrowings into common stock        
Sale of common stock for cash, net of offering costs $ 146 10,001,252 10,001,398
Sale of common stock for cash, net of offering costs (in Shares) 1,464,965        
Cashless stock option exercise $ 1 (1)    
Cashless stock option exercise (in Shares) 5,666        
Net Loss (6,318,818) (6,318,818)
Foreign currency translation   (6,516) (6,516)
Balance at Jun. 30, 2024 $ 1,092 184,164,638 (165,849,353) 6,108 $ 18,322,485
Balance (in Shares) at Jun. 30, 2024 10,920,851       10,920,851
Balance at Mar. 31, 2024 $ 945 173,437,683 (162,588,112) 16,702 $ 10,867,218
Balance (in Shares) at Mar. 31, 2024 9,450,220        
Stock-based compensation 725,704 725,704
Sale of common stock for cash, net of offering costs $ 146 10,001,252 10,001,398
Sale of common stock for cash, net of offering costs (in Shares) 1,464,965        
Cashless stock option exercise $ 1 (1)  
Cashless stock option exercise (in Shares) 5,666        
Net Loss (3,261,241) (3,261,241)
Foreign currency translation (10,594) (10,594)
Balance at Jun. 30, 2024 $ 1,092 $ 184,164,638 $ (165,849,353) $ 6,108 $ 18,322,485
Balance (in Shares) at Jun. 30, 2024 10,920,851       10,920,851
v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (6,318,818) $ (12,462,438)
Adjustments to reconcile net loss with cash flows from operations:    
Stock-based compensation 1,448,675 (1,542,902)
Depreciation and amortization expense 87,412 152,036
Amortization of debt discounts and issuance costs 8,230 689,305
Non-cash recruiting fees 438,000
Shares issued in lieu of interest 387,578
Gain from sale of discontinued operation (216,069)
Loss on debt extinguishment 380,741
Conversion expense 7,476,000
Changes in operating assets and liabilities:    
Accounts receivable (101,390) 219,684
Deferred contract costs (76,973)
Other current assets (497,379) (136,564)
Accounts payable and accrued expenses (411,552) 63,546
Deferred revenue 112,144 (22,211)
Other accrued liabilities 290,000
Adjustments relating to discontinued operations 0 110,064
Net cash flows from operating activities (5,749,651) (4,173,230)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of intangible assets (15,582)
Net cash flows from investing activities (15,582)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock, net of offering costs 10,001,398 6,383,641
Credit facility drawdown, net of issuance costs 543,760
Net cash flows from financing activities 10,001,398 6,927,401
Effect of Foreign Currencies (5,871) (12,206)
Net Change in Cash 4,230,294 2,741,965
Cash, Beginning of the Period 10,177,099 3,237,106
Cash, Beginning of the Period - Discontinued Operations 2,703
Cash, End of the Period - Discontinued Operations
Cash, End of the Period 14,407,393 5,981,773
Supplemental Disclosure of Cash Flow Information:    
Cash paid for interest 15,276
Cash paid for income taxes - discontinued operations 364
Cash paid for income taxes 3,255
Cash paid for income taxes - discontinued operations 1,254
Schedule of Non-cash Investing and Financing Activities:    
Conversion of convertible note payable and accrued interest to common stock 7,856,011
Conversion of credit facility borrowings into common stock 900,000
Warrants for services with the sale of common stock 877,392 725,889
Cashless option and warrant exercises $ 1
v3.24.2.u1
Basis of Presentation
6 Months Ended
Jun. 30, 2024
Basis of Presentation [Abstract]  
BASIS OF PRESENTATION

NOTE 1 – BASIS OF PRESENTATION

 

In the opinion of Management, the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which we considered as necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for future periods or the full year.

 

The condensed consolidated financial statements include the accounts of authID Inc. and its wholly-owned subsidiaries MultiPay S.A.S., ID Solutions, Inc., FIN Holdings Inc., Ipsidy Enterprises Limited and authID Gaming Inc. (collectively the “Company”). All significant intercompany balances and transactions have been eliminated in consolidation.

 

Going Concern

 

As of June 30, 2024, the Company had an accumulated deficit of approximately $165.8 million. For the three and six months ended June 30, 2024, the Company earned revenue from continuing operations of approximately $0.3 million and $0.4 million, used approximately $2.8 million and $5.7 million to fund its operations, and incurred a net loss of approximately $3.3 million and $6.3 million.

 

The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition, and acquiring new clients to generate revenues and cash flows. In June 2024, the Company raised approximately $10.0 million after expenses from existing and new stockholders through the sale of Common Stock pursuant to a registered direct offering. Going forward, the Company plans to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. Our growth-oriented business plan to offer products to our customers will require continued capital investment and there is no guarantee that such financing will be available, or available on acceptable terms.

  

There is no assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.

 

Reclassification

 

Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, for the three and six months ended June 30, 2023, we reclassified approximately $64,000 and $93,000, respectively, in expenses from research and development expenses to general and administrative expenses.

 

Net Loss per Common Share

 

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and six months ended June 30, 2024 and 2023 because their effect was antidilutive:

 

Security  2024   2023 
         
Convertible notes payable   8,277    8,277 
Warrants   697,446    497,895 
Stock options   1,852,819    1,561,070 
    2,558,542    2,067,242 

  

Revenue Recognition

 

Software License – The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated. Variable fees are typically earned over time based on monthly users, transaction volumes or a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price. Transaction fees are billed monthly and are constrained to transactions incurred within the month.

 

For contracts with minimum annual fees, the Company generally recognizes the amount of revenue ratably over the contract year and records contract assets for the amount in excess of monthly contract billings relating to variable contract consideration. For certain contracts, the Company enters into an agreement which stipulates a minimum annual fee which is generally due at the end of the contract year, in excess of the amount of monthly billings. The Company may also require milestone payments of the minimum annual fee. The amount of any billed fees in excess of revenue recognized is recorded as deferred revenue.

 

Any usage-based fees in excess of the minimum contract amount are charged to the customer and allocated to the annual period in which they are earned under the contract. At the beginning of each annual period in the contract, the Company estimates the variable amounts for the annual period subject to the constrained variable consideration (usage-based fees) and recognizes that amount on a time-elapsed basis over the annual period. At each reporting date within an annual period, the Company reassesses its estimate of the excess variable amounts for the annual period and updates the amount recognized on a time-elapsed basis over the remainder of the annual period.

 

The Company had deferred revenue contract liabilities of approximately $244,000 and $132,000 as of June 30, 2024 and December 31, 2023, respectively, for certain revenue that will be earned in future periods. All deferred revenue contract liabilities as of June 30, 2024 are expected to be earned over the next twelve months.

 

Concentration of Revenue and Accounts Receivable

 

For the six months ended June 30, 2024, two customers represented 59% of revenue, respectively. For the six months ended June 30, 2023, one customer represented 47% of revenue. For the three months ended June 30, 2024, three customers represented 76% of revenue, respectively. For the three months ended June 30, 2023, one customer represented 51% of revenue. As of June 30, 2024, three customers accounted for 80% respectively, of accounts receivable. As of December 31, 2023, two customers accounted for 67%, respectively, of accounts receivable.

 

Remaining Performance Obligations

 

As of June 30, 2024, the Company’s Remaining Performance Obligation (RPO) was $4.24 million, of which $0.24 million is held as deferred revenue and $4.00 million is related to other non-cancellable contracted amounts. The Company expects approximately 36% of the RPO to be recognized as revenue over the next twelve months ending June 30, 2025 based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have sufficient historical information to estimate the recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties.

 

Deferred Contract Costs – We defer the portion of sales commission that is considered a cost of obtaining a new contract with a customer and amortize these deferred costs over the period of benefit. We expense the remaining sales commissions as incurred. The following table summarizes deferred contract cost activity for the six months ended June 30, 2024:

 

   Deferred 
   Contract Costs 
     
Carrying Value at December 31, 2023  $157,300 
Additions   8,294 
Amortization   (8,859)
Carrying Value at June 30, 2024  $156,735 
v3.24.2.u1
Other Current Assets
6 Months Ended
Jun. 30, 2024
Other Current Assets [Abstract]  
OTHER CURRENT ASSETS

NOTE 2 – OTHER CURRENT ASSETS

 

Other current assets consisted of the following at June 30, 2024 (unaudited) and December 31, 2023:

 

   June 30,   December 31, 
   2024   2023 
         
Prepaid insurance  $310,205   $184,492 
Prepaid third party services   461,550    291,512 
   $771,755   $476,004 
v3.24.2.u1
Intangible Assets, Net (Other than Goodwill)
6 Months Ended
Jun. 30, 2024
Intangible Assets, Net (Other than Goodwill) [Abstract]  
INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

NOTE 3 – INTANGIBLE ASSETS, NET (OTHER THAN GOODWILL)

 

The Company’s intangible assets primarily consist of acquired and developed software that is being amortized over their estimated useful lives as indicated below. The following is a summary of activity related to intangible assets for the six months ended June 30, 2024 (unaudited):

 

   Acquired and         
   Developed         
   Software   Patents   Total 
             
Useful Lives   5 Years    10 Years      
                
Carrying Value at December 31, 2023  $212,798   $114,203   $327,001 
Additions   
-
    15,582    15,582 
Amortization   (78,585)   (8,827)   (87,412)
Carrying Value at June 30, 2024  $134,213   $120,958   $255,171 

  

The following is a summary of intangible assets as of June 30, 2024 (unaudited):

 

   Acquired and         
   Developed         
   Software   Patents   Total 
Cost  $1,734,662   $180,196   $1,914,858 
Accumulated amortization   (1,600,449)   (59,238)   (1,659,687)
Carrying Value at June 30, 2024  $134,213   $120,958   $255,171 

 

Amortization expense totaled approximately $87,000 and $152,000 for the six months ended June 30, 2024, and 2023, respectively.

 

Future expected amortization of intangible assets is as follows:

 

2024 (Remainder of the Year)  $87,595 
2025   70,889 
2026   20,786 
2027   18,019 
2028   18,019 
Thereafter   39,863 
   $255,171 

 

There were no impairment indicators noted with respect to Company’s long-lived assets, including intangible assets, as of June 30, 2024.

v3.24.2.u1
Accounts Payable and Accrued Expenses
6 Months Ended
Jun. 30, 2024
Accounts Payable and Accrued Expenses [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consisted of the following as of June 30, 2024 (unaudited) and December 31, 2023:

 

   June 30,   December 31, 
   2024   2023 
         
Trade payables  $248,907   $235,606 
Accrued payroll and related obligations   97,168    707,317 
Insurance Premium Liability   245,542    104,226 
Other accrued expenses   406,423    361,816 
   $998,040   $1,408,965 
v3.24.2.u1
Related Party Transactions
6 Months Ended
Jun. 30, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 5 – RELATED PARTY TRANSACTIONS

 

Board of Directors

 

On February 15, 2024, Mr. Joe Trelin tendered his resignation as Chairman and a Director of the Company, effective immediately. On February 20, 2024, the board of directors of the Company (the “Board”) accepted his resignation and agreed to vest the unvested portion of an option granted to Mr. Trelin on June 28, 2023, amounting to 6,511 shares.

 

On March 25, 2024, Mr. Kunal Mehta was appointed as a Director of the Company, upon the standard terms for non-employee Directors. On May 20, 2024, Mr. Mehta was granted an option to purchase 13,282 shares of common stock at an exercise price of $7.78 per share. 12,500 of the shares vest annually in equal amounts over a three-year period commencing in 2025 and 782 shares vested monthly in equal amounts over a three-month period commencing March 2024.

 

Commercial Agreements

 

On June 6, 2023, the Company entered into a services agreement with The Pipeline Group, Inc. (“TPG”). Ken Jisser, a director of the Company, is the founder and CEO of TPG, a technology-enabled services company that aims to deliver business results for companies looking to build a predictable and profitable pipeline. As of June 30, 2024, the Company held a balance of approximately $117,000 in prepaid expenses related to this service agreement. In June 2024, the agreement with TPG was renewed for an additional year at a reduced fee rate of $70,000 per month. Total expense incurred under this contract during the three and six months ended June 30, 2024 was approximately $285,000 and $542,000, respectively. Total expense incurred under this contract during the three and six months ended June 30, 2023 was approximately $67,000 and $99,000, respectively.

 

Employment Agreement

 

Since June 2023, the Company has employed Dale Daguro, the brother of our CEO, Rhon Daguro as a VP Sales. Dale Daguro’s employment is at will and may be terminated at any time, with or without cause. On July 12, 2023, Dale was granted an option to purchase 25,000 shares of common stock at an exercise price of $7.36 and on December 21, 2023 he was granted a further option to purchase 4,000 shares of common stock at an exercise price of $9.25 per share. Dale’s compensation is commensurate with other executives employed by the Company at a similar level of seniority and experience. During the six months ended June 30, 2024, Dale Daguro earned approximately $148,000 in base salary and sales commission.

 

Issuance of Common Stock

 

On June 27, 2024, Michael Thompson, a Director of the Company purchased 12,254 shares of the Company’s common stock at an aggregate price of $100,000, as part of the Company’s Registered Direct offering (See Note 6 – Stockholders’ Equity).

v3.24.2.u1
Stockholders' Equity
6 Months Ended
Jun. 30, 2024
Stockholders Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 6STOCKHOLDERS’ EQUITY

 

Common Stock

 

On June 27, 2024, pursuant to Securities Purchase Agreements in a Registered Direct Offering, the Company issued 1,464,965 shares of common stock for cash gross proceeds of approximately $11.0 million (or approximately $10.0 million, net of offering costs).

 

During the six months ended June 30, 2024 the Company issued 5,666 shares of common stock, upon the cashless exercise of a stock option.

 

During the six months ended June 30, 2023, shares of common stock were issued as a result of the following transactions:

 

On May 26, 2023, pursuant to Securities Purchase Agreements, the Company issued 1,989,676 shares of common stock for cash gross proceeds of approximately $7.3 million (or approximately $6.4 million, net of offering costs).

 

On May 26, 2023, pursuant to a Securities Purchase Agreement, Mr. Garchik capitalized the outstanding principal balance of $900,000 under the Initial Promissory Note, into 245,634 shares of common stock.

 

On May 26, 2023, pursuant to an exchange agreement with Holders of Convertible Notes payable, the Company issued 2,348,347 shares of common stock in exchange for Convertible Notes in the gross principal amount of approximately $8.9 million (approximately $7.9 million, net of debt issuance costs and discount). In addition, the Company recorded approximately $7.5 million of expense on conversion of convertible notes.

 

The Company issued 111,516 shares of common stock for approximately $388,000 of interest accrued under the Convertible Notes and Credit Facility.

 

Warrants

  

On June 27, 2024, in connection with their placement agent services, the Company issued 102,547 common stock warrants to Madison Global Partners, LLC, with a term of 5 years and an exercise price of $7.50 per share.

 

During the six months ended June 30, 2023, warrants were issued as a result of the following transactions:

 

On May 26, 2023, in connection with their placement agent services, the Company issued 156,712 common stock warrants to Madison Global Partners, LLC, with a term of 5 years and an exercise price of $3.664 per share.

 

On May 12, 2023, in connection with certain recruitment services, the Company issued 187,500 common stock warrants to Madison III, LLC with a term of 5 years and an exercise price of $3.164 per share. 

 

The following is a summary of the Company’s warrant activity for the six months ended June 30, 2024 (unaudited):

 

       Weighted   Weighted 
       Average   Average 
   Number of   Exercise   Remaining 
   Shares   Price   Life 
Outstanding, December 31, 2023   598,267   $11.89    3.9 Years 
Granted   102,547   $7.50    5.0 Years 
Exercised/Cancelled   (3,368)  $21.12    - 
Outstanding, June 30, 2024   697,446   $11.20    3.7 Years 

 

Stock Options

 

During the six months ended June 30, 2024, the Company granted Mr. Kunal Mehta 13,282 options to purchase common stock at an exercise price of $7.78 per share. During the six months ended June 30, 2024, the Company also granted a total of 100,000 options to certain new employees at exercise prices ranging from $9.05 to $9.61 per share.

 

During the six months ended June 30, 2024 the Company agreed to accelerate the vesting of 6,511 options for Mr. Joe Trelin under the terms of his resignation with an exercise price of $5.48 per share. These accelerated options would not otherwise have vested prior to termination of service according to their Service conditions. Therefore, the Company recalculated the fair value of these options as of his resignation date of February 20, 2024 using the Black Scholes method.

  

The Company determined the grant date fair value of options granted for the six months ended June 30, 2024, using the Black Scholes Method, as applicable, with the following assumptions:

 

Expected volatility   122 – 123%
Expected term   5 years
Risk free rate   3.80% - 4.46%
Dividend rate   0.00%

 

Activity related to stock options for the six months ended June 30, 2024 (unaudited), is summarized as follows:

 

   Number
of
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Contractual
Term (Yrs.)
   Aggregate
Intrinsic
Value
 
                 
Outstanding at December 31, 2023   1,796,743   $25.20    6.5   $3,630,733 
Granted   113,282   $9.19    10.0   $15,540 
Exercised   (15,625)  $5.48    
-
   $
-
 
Forfeited/cancelled   (41,581)  $24.88    6.5   $
-
 
Outstanding as of June 30, 2024   1,852,819   $24.43    6.2   $4,583,031 
Exercisable as of June 30, 2024   1,227,820   $29.32    5.1   $2,422,237 

 

The following table summarizes stock option information as of June 30, 2024 (unaudited):  

 

       Weighted     
       Average     
       Contractual     
Exercise Price  Outstanding   Term (Yrs.)   Exercisable 
             
$2.64 – $5.00   342,628    8.8    193,339 
$5.01 – $10.00   651,381    9.1    269,719 
$10.01 – $15.00   43,078    2.4    43,078 
$15.01 – $20.00   252,084    1.3    252,084 
$20.01 – $121.28   563,648    3.8    469,600 
    1,852,819    6.2    1,227,820 

 

During the six months ended June 30, 2024, the Company recognized approximately $1.5 million of stock option-based compensation expense. As of June 30, 2024, there was approximately $1.8 million of unrecognized compensation costs related to stock options outstanding that will be expensed through 2027.

 

On May 24, 2024, the Board of Directors adopted the 2024 Equity Incentive Plan (the “2024 Plan”). On June 26, 2024, the stockholders approved and ratified the 2024 Plan and the allocation of 395,000 shares of Common Stock to the 2024 Plan, in addition to the remaining shares not allocated to awards under the 2021 Equity Incentive Plan and any shares, which become available as a result of the forfeiture, or cancellation of any previous awards. As of June 30, 2024, there were 444,115 shares allocated to and available for issuance of awards under the 2024 Plan but no such awards have yet been granted.

v3.24.2.u1
Commitments and Contingencies
6 Months Ended
Jun. 30, 2024
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

 

From time to time the Company is a party to various legal or administrative proceedings arising in the ordinary course of our business. While any litigation contains an element of uncertainty, we have no reason to believe that the outcome of such proceedings will have a material adverse effect on the financial condition or results of operations of the Company.

 

Leases

 

The Company has no remaining lease agreements as of July 2023.

v3.24.2.u1
Subsequent Events
6 Months Ended
Jun. 30, 2024
Subsequent Event [Abstract]  
SUBSEQUENT EVENTS

NOTE 8 – SUBSEQUENT EVENTS

 

In July 2024, the Company evaluated the rollout timelines for several customers who have delayed go-live adoption dates due to their respective corporate processes and timelines. The Company has come to a verbal agreement with one customer (who comprises $1.3 million of the Company’s RPO) to modify the terms of their contract to defer the timing of their minimum payment obligations by approximately 12 months. The Company expects this modification agreement to be finalized during the quarter ending September 30, 2024, resulting in a reduction in the future periodic recognition of the revenue associated with this performance obligation through the end of the initial contract period, December 31, 2027. The proposed modification is not expected to affect the overall RPO associated with this customer’s contract.

 

In August 2024, the Board adopted a new policy on compensation for non-employee directors, which is summarized as follows

 

Each non-employee director will receive:

 

Total annual compensation equal to $125,000, payable in cash and equity.

 

Annual cash compensation of $8,000, or $10,000 if they are a committee chair, payable quarterly in arrear.

 

Annual equity compensation of $117,000 by way of an option grant to purchase common stock. The number of shares which will be the subject of each grant shall be determined by reference to the Black Scholes value of the grant based on the closing price of the common stock, as reported by the NASDAQ Stock Market (or such other principal securities exchange or market system on which the common stock is then listed,) on the date of the Annual Meeting, at which the director is re-elected by the stockholders to serve on the Board. Each stock option shall be a non-qualified stock option with a term of 10 years and shall become fully vested on the first anniversary of the grant date, with equal monthly vesting over a 12 month period, provided that such non-employee director remains as a director of the Company during such 12 month period. Each such option shall have an exercise price equal to the closing price of the common stock, as reported by the NASDAQ Stock Market, on the grant date. The grant date may be deferred in accordance with the Company’s Policy on Granting Equity Awards, if the Annual Meeting is held during a closed trading window.

 

In accordance with this new policy, each non-employee director will receive an option grant of 15,627 shares, on the third day after the announcement of the Company’s results for the period ended June 30, 2024, at an exercise price equal to the closing price of the common stock on the NASDAQ Stock Market on that day.

v3.24.2.u1
Pay vs Performance Disclosure - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ (3,261,241) $ (10,678,557) $ (6,318,818) $ (12,462,438)
v3.24.2.u1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.2.u1
Accounting Policies, by Policy (Policies)
6 Months Ended
Jun. 30, 2024
Basis of Presentation [Abstract]  
Going Concern

Going Concern

As of June 30, 2024, the Company had an accumulated deficit of approximately $165.8 million. For the three and six months ended June 30, 2024, the Company earned revenue from continuing operations of approximately $0.3 million and $0.4 million, used approximately $2.8 million and $5.7 million to fund its operations, and incurred a net loss of approximately $3.3 million and $6.3 million.

The continuation of the Company as a going concern is dependent upon financial support from the Company’s stockholders, the ability of the Company to obtain additional debt or equity financing to continue operations, the Company’s ability to generate sufficient cash flows from operations, successfully locating and negotiating with other business entities for potential acquisition, and acquiring new clients to generate revenues and cash flows. In June 2024, the Company raised approximately $10.0 million after expenses from existing and new stockholders through the sale of Common Stock pursuant to a registered direct offering. Going forward, the Company plans to raise additional funds to support its operations and investments as it seeks to create a sustainable organization. Our growth-oriented business plan to offer products to our customers will require continued capital investment and there is no guarantee that such financing will be available, or available on acceptable terms.

There is no assurance that the Company will ever be profitable. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern. As there can be no assurance that the Company will be able to achieve positive cash flows (become cash flow positive) and raise sufficient capital to maintain operations, there is substantial doubt about the Company’s ability to continue as a going concern.

Reclassification

Reclassification

Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, for the three and six months ended June 30, 2023, we reclassified approximately $64,000 and $93,000, respectively, in expenses from research and development expenses to general and administrative expenses.

 

Net Loss per Common Share

Net Loss per Common Share

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share”. ASC 260 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the statement of operations. Basic EPS is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and six months ended June 30, 2024 and 2023 because their effect was antidilutive:

Security  2024   2023 
         
Convertible notes payable   8,277    8,277 
Warrants   697,446    497,895 
Stock options   1,852,819    1,561,070 
    2,558,542    2,067,242 
Revenue Recognition

Revenue Recognition

Software License – The Company recognizes revenue based on the identified performance obligations over the performance period for fixed consideration and / or variable fees generated. Variable fees are typically earned over time based on monthly users, transaction volumes or a monthly flat fee rate. We allocate the selling price in a contract which has multiple performance obligations based on the contract selling price that we believe represents a fair market price for the service rendered based on estimated standalone selling price. Transaction fees are billed monthly and are constrained to transactions incurred within the month.

For contracts with minimum annual fees, the Company generally recognizes the amount of revenue ratably over the contract year and records contract assets for the amount in excess of monthly contract billings relating to variable contract consideration. For certain contracts, the Company enters into an agreement which stipulates a minimum annual fee which is generally due at the end of the contract year, in excess of the amount of monthly billings. The Company may also require milestone payments of the minimum annual fee. The amount of any billed fees in excess of revenue recognized is recorded as deferred revenue.

Any usage-based fees in excess of the minimum contract amount are charged to the customer and allocated to the annual period in which they are earned under the contract. At the beginning of each annual period in the contract, the Company estimates the variable amounts for the annual period subject to the constrained variable consideration (usage-based fees) and recognizes that amount on a time-elapsed basis over the annual period. At each reporting date within an annual period, the Company reassesses its estimate of the excess variable amounts for the annual period and updates the amount recognized on a time-elapsed basis over the remainder of the annual period.

The Company had deferred revenue contract liabilities of approximately $244,000 and $132,000 as of June 30, 2024 and December 31, 2023, respectively, for certain revenue that will be earned in future periods. All deferred revenue contract liabilities as of June 30, 2024 are expected to be earned over the next twelve months.

Concentration of Revenue and Accounts Receivable

Concentration of Revenue and Accounts Receivable

For the six months ended June 30, 2024, two customers represented 59% of revenue, respectively. For the six months ended June 30, 2023, one customer represented 47% of revenue. For the three months ended June 30, 2024, three customers represented 76% of revenue, respectively. For the three months ended June 30, 2023, one customer represented 51% of revenue. As of June 30, 2024, three customers accounted for 80% respectively, of accounts receivable. As of December 31, 2023, two customers accounted for 67%, respectively, of accounts receivable.

 

Remaining Performance Obligations

Remaining Performance Obligations

As of June 30, 2024, the Company’s Remaining Performance Obligation (RPO) was $4.24 million, of which $0.24 million is held as deferred revenue and $4.00 million is related to other non-cancellable contracted amounts. The Company expects approximately 36% of the RPO to be recognized as revenue over the next twelve months ending June 30, 2025 based on contractual commitments and expected usage patterns. However, the amount and timing of revenue recognition are generally dependent upon customers’ future consumption, which is inherently variable at customers’ discretion. Furthermore, the Company does not have sufficient historical information to estimate the recognition of revenue due to its current operations and has approximated such amount based on discussions with the contracted parties.

Deferred Contract Costs – We defer the portion of sales commission that is considered a cost of obtaining a new contract with a customer and amortize these deferred costs over the period of benefit. We expense the remaining sales commissions as incurred. The following table summarizes deferred contract cost activity for the six months ended June 30, 2024:

   Deferred 
   Contract Costs 
     
Carrying Value at December 31, 2023  $157,300 
Additions   8,294 
Amortization   (8,859)
Carrying Value at June 30, 2024  $156,735 
v3.24.2.u1
Basis of Presentation (Tables)
6 Months Ended
Jun. 30, 2024
Basis of Presentation [Abstract]  
Schedule of Diluted Loss per Share The following potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and six months ended June 30, 2024 and 2023 because their effect was antidilutive:
Security  2024   2023 
         
Convertible notes payable   8,277    8,277 
Warrants   697,446    497,895 
Stock options   1,852,819    1,561,070 
    2,558,542    2,067,242 
Schedule of Deferred Contract Cost Activity The following table summarizes deferred contract cost activity for the six months ended June 30, 2024:
   Deferred 
   Contract Costs 
     
Carrying Value at December 31, 2023  $157,300 
Additions   8,294 
Amortization   (8,859)
Carrying Value at June 30, 2024  $156,735 
v3.24.2.u1
Other Current Assets (Tables)
6 Months Ended
Jun. 30, 2024
Other Current Assets [Abstract]  
Schedule of Other Current Assets Other current assets consisted of the following at June 30, 2024 (unaudited) and December 31, 2023:
   June 30,   December 31, 
   2024   2023 
         
Prepaid insurance  $310,205   $184,492 
Prepaid third party services   461,550    291,512 
   $771,755   $476,004 
v3.24.2.u1
Intangible Assets, Net (Other than Goodwill) (Tables)
6 Months Ended
Jun. 30, 2024
Intangible Assets, Net (Other than Goodwill) [Abstract]  
Schedule of Intangible Assets The following is a summary of activity related to intangible assets for the six months ended June 30, 2024 (unaudited):
   Acquired and         
   Developed         
   Software   Patents   Total 
             
Useful Lives   5 Years    10 Years      
                
Carrying Value at December 31, 2023  $212,798   $114,203   $327,001 
Additions   
-
    15,582    15,582 
Amortization   (78,585)   (8,827)   (87,412)
Carrying Value at June 30, 2024  $134,213   $120,958   $255,171 

  

The following is a summary of intangible assets as of June 30, 2024 (unaudited):
   Acquired and         
   Developed         
   Software   Patents   Total 
Cost  $1,734,662   $180,196   $1,914,858 
Accumulated amortization   (1,600,449)   (59,238)   (1,659,687)
Carrying Value at June 30, 2024  $134,213   $120,958   $255,171 
Schedule of Future Amortization of Intangible Assets Future expected amortization of intangible assets is as follows:
2024 (Remainder of the Year)  $87,595 
2025   70,889 
2026   20,786 
2027   18,019 
2028   18,019 
Thereafter   39,863 
   $255,171 
v3.24.2.u1
Accounts Payable and Accrued Expenses (Tables)
6 Months Ended
Jun. 30, 2024
Accounts Payable and Accrued Expenses [Abstract]  
Schedule of Accounts Payable and Accrued Expenses Accounts payable and accrued expenses consisted of the following as of June 30, 2024 (unaudited) and December 31, 2023:
   June 30,   December 31, 
   2024   2023 
         
Trade payables  $248,907   $235,606 
Accrued payroll and related obligations   97,168    707,317 
Insurance Premium Liability   245,542    104,226 
Other accrued expenses   406,423    361,816 
   $998,040   $1,408,965 
v3.24.2.u1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2024
Stockholders Equity [Abstract]  
Schedule of Warrant Activity The following is a summary of the Company’s warrant activity for the six months ended June 30, 2024 (unaudited):
       Weighted   Weighted 
       Average   Average 
   Number of   Exercise   Remaining 
   Shares   Price   Life 
Outstanding, December 31, 2023   598,267   $11.89    3.9 Years 
Granted   102,547   $7.50    5.0 Years 
Exercised/Cancelled   (3,368)  $21.12    - 
Outstanding, June 30, 2024   697,446   $11.20    3.7 Years 
Schedule of Grant Date Fair Value of Options Granted The Company determined the grant date fair value of options granted for the six months ended June 30, 2024, using the Black Scholes Method, as applicable, with the following assumptions:
Expected volatility   122 – 123%
Expected term   5 years
Risk free rate   3.80% - 4.46%
Dividend rate   0.00%
Schedule of Stock Options Activity related to stock options for the six months ended June 30, 2024 (unaudited), is summarized as follows:
   Number
of
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Contractual
Term (Yrs.)
   Aggregate
Intrinsic
Value
 
                 
Outstanding at December 31, 2023   1,796,743   $25.20    6.5   $3,630,733 
Granted   113,282   $9.19    10.0   $15,540 
Exercised   (15,625)  $5.48    
-
   $
-
 
Forfeited/cancelled   (41,581)  $24.88    6.5   $
-
 
Outstanding as of June 30, 2024   1,852,819   $24.43    6.2   $4,583,031 
Exercisable as of June 30, 2024   1,227,820   $29.32    5.1   $2,422,237 

 

Schedule of Stock Option Information The following table summarizes stock option information as of June 30, 2024 (unaudited):
       Weighted     
       Average     
       Contractual     
Exercise Price  Outstanding   Term (Yrs.)   Exercisable 
             
$2.64 – $5.00   342,628    8.8    193,339 
$5.01 – $10.00   651,381    9.1    269,719 
$10.01 – $15.00   43,078    2.4    43,078 
$15.01 – $20.00   252,084    1.3    252,084 
$20.01 – $121.28   563,648    3.8    469,600 
    1,852,819    6.2    1,227,820 
v3.24.2.u1
Basis of Presentation (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Basis of Presentation (Details) [Line Items]          
Accumulated deficit $ (165,849,353)   $ (165,849,353)   $ (159,530,535)
Revenue 280,438 $ 37,142 437,816 $ 74,998  
Operations (2,800,000)   (5,749,651) (4,173,230)  
Operations, and incurred a net loss (3,261,241) (10,900,320) (6,318,818) (12,681,946)  
Raised after expenses     10,000,000    
Reclassification to general and administrative expenses   $ 64,000   $ 93,000  
Deferred revenue contract liabilities 244,000   244,000   132,000
Remaining performance obligation 4,240,000   4,240,000    
Deferred revenue $ 243,772   243,772   $ 131,628
Non cancellable contracted amounts     $ 4,000,000    
Percentage of remaining performance obligation 36.00%   36.00%    
Customer Concentration Risk [Member] | Three Customer [Member] | Revenue Benchmark [Member]          
Basis of Presentation (Details) [Line Items]          
Concentration percentage 76.00%   59.00%    
Customer Concentration Risk [Member] | One Customer [Member] | Revenue Benchmark [Member]          
Basis of Presentation (Details) [Line Items]          
Concentration percentage   51.00%   47.00%  
Customer Concentration Risk [Member] | One Customer [Member] | Accounts Receivable [Member]          
Basis of Presentation (Details) [Line Items]          
Concentration percentage     80.00%   67.00%
v3.24.2.u1
Basis of Presentation (Details) - Schedule of Diluted Loss per Share - shares
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Schedule of Diluted Loss per Share [Line Items]    
Total dilutive securities 2,558,542 2,067,242
Convertible Notes Payable [Member]    
Schedule of Diluted Loss per Share [Line Items]    
Total dilutive securities 8,277 8,277
Warrant [Member]    
Schedule of Diluted Loss per Share [Line Items]    
Total dilutive securities 697,446 497,895
Stock options [Member]    
Schedule of Diluted Loss per Share [Line Items]    
Total dilutive securities 1,852,819 1,561,070
v3.24.2.u1
Basis of Presentation (Details) - Schedule of Deferred Contract Cost Activity
6 Months Ended
Jun. 30, 2024
USD ($)
Schedule of Deferred Contract Cost Activity [Abstract]  
Carrying Value at December 31, 2023 $ 157,300
Additions 8,294
Amortization (8,859)
Carrying Value at June 30, 2024 $ 156,735
v3.24.2.u1
Other Current Assets (Details) - Schedule of Other Current Assets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Other Current Assets [Abstract]    
Prepaid insurance $ 310,205 $ 184,492
Prepaid third party services 461,550 291,512
Total other current assets $ 771,755 $ 476,004
v3.24.2.u1
Intangible Assets, Net (Other than Goodwill) (Details) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Finite-Lived Intangible Assets [Member]    
Intangible Assets, Net (Other than Goodwill) (Details) [Line Items]    
Amortization expense $ 87,000 $ 152,000
v3.24.2.u1
Intangible Assets, Net (Other than Goodwill) (Details) - Schedule of Intangible Assets - USD ($)
6 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Schedule of Intangible Assets [Line Items]    
Carrying Value, Beginning $ 327,001  
Additions 15,582  
Amortization (87,412)  
Carrying Value, ending 255,171  
Cost 1,914,858  
Accumulated amortization (1,659,687)  
Carrying Value at June 30, 2024 $ 255,171 $ 327,001
Acquired and Developed Software [Member]    
Schedule of Intangible Assets [Line Items]    
Useful Lives 5 years  
Carrying Value, Beginning $ 212,798  
Additions  
Amortization (78,585)  
Carrying Value, ending 134,213  
Cost 1,734,662  
Accumulated amortization (1,600,449)  
Carrying Value at June 30, 2024 $ 134,213  
Patents [Member]    
Schedule of Intangible Assets [Line Items]    
Useful Lives 10 years  
Carrying Value, Beginning $ 114,203  
Additions 15,582  
Amortization (8,827)  
Carrying Value, ending 120,958  
Cost 180,196  
Accumulated amortization (59,238)  
Carrying Value at June 30, 2024 $ 120,958  
v3.24.2.u1
Intangible Assets, Net (Other than Goodwill) (Details) - Schedule of Future Amortization of Intangible Assets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Schedule of Future Amortization of Intangible Assets [Abstract]    
2024 (Remainder of the Year) $ 87,595  
2025 70,889  
2026 20,786  
2027 18,019  
2028 18,019  
Thereafter 39,863  
Total $ 255,171 $ 327,001
v3.24.2.u1
Accounts Payable and Accrued Expenses (Details) - Schedule of Accounts Payable and Accrued Expenses - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Accounts Payable and Accrued Expenses [Abstract]    
Trade payables $ 248,907 $ 235,606
Accrued payroll and related obligations 97,168 707,317
Insurance Premium Liability 245,542 104,226
Other accrued expenses 406,423 361,816
Total $ 998,040 $ 1,408,965
v3.24.2.u1
Related Party Transactions (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 27, 2024
May 20, 2024
Dec. 21, 2023
Jul. 12, 2023
Jun. 28, 2023
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Related Party Transactions [Line Items]                    
Unvested option granted (in Shares)                 15,627  
Option to purchase shares of common stock (in Shares) 12,254   4,000 25,000     12,500      
Exercise price (in Dollars per share)   $ 7.78 $ 9.25 $ 7.36            
Shares vested (in Shares)             782      
Prepaid expenses           $ 117,000     $ 117,000  
Fee rate                 70,000  
Other Expenses           $ 285,000   $ 67,000 542,000 $ 99,000
Salary and sales commission                 $ 148,000  
Aggregate price $ 100,000                  
Mr. Trelin [Member]                    
Related Party Transactions [Line Items]                    
Unvested option granted (in Shares)         6,511          
Mr. Kunal Mehta [Member]                    
Related Party Transactions [Line Items]                    
Option to purchase shares of common stock (in Shares)   13,282                
v3.24.2.u1
Stockholders' Equity (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 27, 2024
May 26, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 26, 2024
Dec. 31, 2023
May 12, 2023
Stockholders’ Equity [Line Items]                  
Common shares issued 1,464,965   10,920,851   10,920,851     9,450,220  
Gross proceeds (in Dollars) $ 11,000,000 $ 7,300,000     $ 10,001,398 $ 6,383,641      
Offering costs (in Dollars) $ 10,000,000 $ 6,400,000              
Exercised shares         15,625        
Stock Issued During Period, Shares, New Issues   1,989,676              
Outstanding principal balance (in Dollars)   $ 900,000              
Shares of common stock   245,634              
Common stock exchange for Convertible Notes   2,348,347              
Debt issuance costs and discount (in Dollars)   $ 7,900,000              
Expense on conversion of convertible notes (in Dollars)   $ 7,500,000              
Granted shares         113,282        
Exercise price (in Dollars per share)         $ 9.19        
Option exercise price range shares     1,852,819   1,852,819        
Allocation of shares     444,115   444,115   395,000    
Warrant [Member]                  
Stockholders’ Equity [Line Items]                  
Granted total of stock options 102,547 156,712             187,500
Maturity term of warrant 5 years 5 years             5 years
Warrant exercise price (in Dollars per share) $ 7.5 $ 3.664             $ 3.164
Convertible Note Payable [Member]                  
Stockholders’ Equity [Line Items]                  
Gross principal amount (in Dollars)   $ 8,900,000              
Stock Options [Member]                  
Stockholders’ Equity [Line Items]                  
Option exercise price range shares     100,000   100,000        
Stock Options [Member] | Minimum [Member]                  
Stockholders’ Equity [Line Items]                  
Exercise price range lower (in Dollars per share)         $ 9.05        
Stock Options [Member] | Maximum [Member]                  
Stockholders’ Equity [Line Items]                  
Exercise price range upper (in Dollars per share)         $ 9.61        
Common Stock [Member]                  
Stockholders’ Equity [Line Items]                  
Exercised shares         5,666        
Stock Issued During Period, Shares, New Issues     1,464,965 1,989,676 1,464,965 1,989,676      
Common stock exchange for Convertible Notes       2,348,347   2,348,347      
Convertible notes shares issued         111,516        
Interest accrued amount (in Dollars)         $ 388,000        
Stock Options [Member]                  
Stockholders’ Equity [Line Items]                  
Stock option based compensation expense (in Dollars)         1,500,000        
Unrecognized compensation costs (in Dollars)     $ 1,800,000   $ 1,800,000        
Mr. Kunal Mehta [Member] | Stock Options [Member]                  
Stockholders’ Equity [Line Items]                  
Granted shares         13,282        
Exercise price (in Dollars per share)         $ 7.78        
Mr. Joe Trelin [Member] | Stock Options [Member]                  
Stockholders’ Equity [Line Items]                  
Exercise price (in Dollars per share)         $ 5.48        
Accelerate vesting shares         6,511        
v3.24.2.u1
Stockholders' Equity (Details) - Schedule of Warrant Activity - Warrant [Member] - $ / shares
6 Months Ended
Dec. 31, 2023
Jun. 30, 2024
Stockholders' Equity (Details) - Schedule of Warrant Activity [Line Items]    
Number of Shares, Outstanding 598,267 697,446
Weighted Average Exercise Price, Outstanding $ 11.89 $ 11.2
Weighted Average Remaining Life, Outstanding 3 years 10 months 24 days 3 years 8 months 12 days
Number of Shares, Granted   102,547
Weighted Average Exercise Price, Granted   $ 7.5
Weighted Average Remaining Life, Granted   5 years
Number of Shares, Exercised/Cancelled   (3,368)
Weighted Average Exercise Price, Exercised/Cancelled   $ 21.12
v3.24.2.u1
Stockholders' Equity (Details) - Schedule of Grant Date Fair Value of Options Granted
6 Months Ended
Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Expected term 5 years
Dividend rate 0.00%
Minimum [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Expected volatility 122.00%
Risk free rate 3.80%
Maximum [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Expected volatility 123.00%
Risk free rate 4.46%
v3.24.2.u1
Stockholders' Equity (Details) - Schedule of Stock Options - USD ($)
6 Months Ended
Dec. 31, 2023
Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Outstanding 1,796,743 1,852,819
Weighted Average Exercise Price, Outstanding $ 25.2 $ 24.43
Weighted Average Contractual Term (Yrs.), Outstanding 6 years 6 months 6 years 2 months 12 days
Aggregate Intrinsic Value, Outstanding $ 3,630,733 $ 4,583,031
Number of Shares, Exercisable   1,227,820
Weighted Average Exercise Price, Exercisable   $ 29.32
Weighted Average Contractual Term (Yrs.), Exercisable   5 years 1 month 6 days
Aggregate Intrinsic Value, Exercisable   $ 2,422,237
Number of Shares, Granted   113,282
Weighted Average Exercise Price, Granted   $ 9.19
Weighted Average Contractual Term (Yrs.), Granted   10 years
Aggregate Intrinsic Value, Granted   $ 15,540
Number of Shares, Exercised   (15,625)
Weighted Average Exercise Price, Exercised   $ 5.48
Weighted Average Contractual Term (Yrs.),Exercised  
Aggregate Intrinsic Value, Exercised  
Number of Shares, Forfeited/cancelled   (41,581)
Weighted Average Exercise Price, Forfeited/cancelled   $ 24.88
Weighted Average Contractual Term (Yrs.), Forfeited/cancelled   6 years 6 months
Aggregate Intrinsic Value, Forfeited/cancelled  
v3.24.2.u1
Stockholders' Equity (Details) - Schedule of Stock Option Information
6 Months Ended
Jun. 30, 2024
shares
Schedule of Stock Option Information [Line Items]  
Outstanding 1,852,819
Weighted Average Contractual Term (Yrs.) 6 years 2 months 12 days
Exercisable 1,227,820
$2.64 – $5.00 [Member]  
Schedule of Stock Option Information [Line Items]  
Outstanding 342,628
Weighted Average Contractual Term (Yrs.) 8 years 9 months 18 days
Exercisable 193,339
$5.01 – $10.00 [Member]  
Schedule of Stock Option Information [Line Items]  
Outstanding 651,381
Weighted Average Contractual Term (Yrs.) 9 years 1 month 6 days
Exercisable 269,719
$10.01 – $15.00 [Member]  
Schedule of Stock Option Information [Line Items]  
Outstanding 43,078
Weighted Average Contractual Term (Yrs.) 2 years 4 months 24 days
Exercisable 43,078
$15.01 – $20.00 [Member]  
Schedule of Stock Option Information [Line Items]  
Outstanding 252,084
Weighted Average Contractual Term (Yrs.) 1 year 3 months 18 days
Exercisable 252,084
$20.01 – $121.28 [Member]  
Schedule of Stock Option Information [Line Items]  
Outstanding 563,648
Weighted Average Contractual Term (Yrs.) 3 years 9 months 18 days
Exercisable 469,600
v3.24.2.u1
Subsequent Events (Details) - USD ($)
6 Months Ended
Jul. 31, 2024
Jun. 30, 2024
Subsequent Events (Details) [Line Items]    
Total Annual Compensation Equal   $ 125,000
Annual cash compensation   8,000
Outstanding compensation payable in quarterly   10,000
Annual equity compensation   $ 117,000
Stock option term   10 years
Shares option (in Shares)   15,627
Subsequent Event [Member] | Remaining Performance Obligation [Member]    
Subsequent Events (Details) [Line Items]    
Contract to defer minimum payment $ 1,300,000  

authID (NASDAQ:AUID)
Historical Stock Chart
From Jul 2024 to Aug 2024 Click Here for more authID Charts.
authID (NASDAQ:AUID)
Historical Stock Chart
From Aug 2023 to Aug 2024 Click Here for more authID Charts.